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Article brings back memories
I was happy to see the article 
in your Spring issue regard-
ing Seymour Lipsky on page 22 
[Building a Better Mousetrap 
(and Mouse), Yale Medicine, 
Spring 2014]. The picture, how-
ever, should have been dated 
1958 and the caption should 
have stated that the research 
being done at that time and 
through the early 1960s 
was the development of gas 
chromatography.
I was a colleague of Dr. 
Lipsky during those years and 
co-authored about 20 research 
papers with Dr. Lipsky and such 
others as James Lovelock in the 
development of this new tech-
nique. I also used the technique 
in collaboration with Dr. Lou 
Gluck in his search to identify 
the surfactant material in the 
lungs of newborns.
So thank you for reviving 
some old memories for me.
Robert A. Landowne, Ph.D. ’58 
Westport, Conn.
Thanks to Dr. Landowne for clari-
fying and adding to the record 
of this historic achievement. The 
photograph is indeed from 1958 
and shows instrumentation for 
gas chromatography, an advance 
that contributed to the develop-
ment of a related method, high-
performance liquid chromatog-
raphy, in the 1960s.
Thanks for your latest issue
I wanted to congratulate you on 
the latest issue of Yale Medicine 
[Spring 2014]! I literally read it 
cover to cover. The articles are 
diversely fascinating, deftly 
combining science and human 
interest, and the colorful design 
is beautiful and inviting. Thanks 
to the magazine, although I 
have left New Haven, I feel as 
though I’m still in touch with 
what’s going on at Yale, both in 
the lab and in the clinic. Thanks 
so much for your work on this 
ingenious issue!
Michaela Panter, Ph.D. ’12 
New York, N.Y.
S E C ON D OPI N ION 
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W H AT D OE S I T M E A N T O B E R E S I L I E N T? While exploring this  
topic for this issue of Yale Medicine, we asked students and  
faculty (see excerpts on pp 30–31), including Dean Robert J. 
Alpern, M.D. He shared his thoughts from the vantage points  
of an administrator managing a billion-dollar-plus budget,  
a faculty member interested in the work of colleagues, and a  
basic researcher who ran his own labs in California, Texas,  
and at Yale. 
What is resilience? The ability to survive is based on homeo-
static mechanisms that maintain our bodies in a constant state, 
in spite of a variable environment. So the temperature outside 
goes up and down, but our bodies remain at about 98.6 degrees, 
as long as we’re healthy. That’s homeostasis. 
When we talk about resilience, we refer to the ability of the 
homeostatic mechanisms to function within environmental 
extremes. This plays a role in health from so many perspec-
tives: psychological resilience after trauma, the body’s ability 
to heal after an injury or severe infections, the resilience of 
communities and populations, just to name a few.
As a nephrologist, can you discuss how the kidney figures into 
this topic? If you ingest a low-sodium diet, the kidney retains 
sodium. If you eat a high-sodium diet, the kidney excretes 
sodium. The kidney is all about homeostasis and resilience.
What about deans? Do they have a homeostasis mechanism?  
A colleague once said to me that the reason there are more 
nephrologists serving as deans than from other specialties  
is because nephrologists understand that what goes in has  
to equal what comes out. So we’re very good at balancing  
budgets and addressing extreme homeostatic challenges to  
the institution.
What kinds of challenges? A medical school operates in an 
always-changing environment, and we have to maintain our 
excellence in the midst of this—changes in health care law, the 
competitive environment, NIH regulations, NIH budgets. And 
sometimes they’re extreme: sequestration for example. You 
need to be resilient.
  “A medical school operates in  
















“H E L L O, M Y NA M E I S  JO S H G OR D ON from Columbia 
University, and I’m going to show you how to build your 
brain out of Play-Doh,” said Gordon, M.D., Ph.D. Two hun-
dred psychiatry residency program directors from across 
the country watched Gordon on a video on their laptops, 
tablets, and other personal devices at the 2014 BRAIN 
Conference—the one-day, neuroscience-focused pre- 
meeting to the American Association of Directors of 
Psychiatric Residency Training conference in March in 
Tucson, Ariz. Gordon made the instructional video after  
the conference workshops were beta-tested ahead of time  
in New York. “Josh is something of a Play-Doh savant,”  
said David A. Ross, Ph.D. ’04, M.D. ’05, assistant professor  
of psychiatry, who helped plan the event. While many  
beta testers struggled to assemble the building blocks of  
the brain, Gordon was sculpting NMDA receptors, critical 
cellular structures for learning and memory. “It was stun-
ning,” said Ross. At the conference, the residency program 
directors molded their own Play-Doh brains, following 
along as Gordon explained that the wad of yellow Play-Doh 
on their screens was the brain stem—a conduit through the  
spinal cord between the brain and the rest of the body.  
Layer by layer, from the multicolored blobs of nontoxic 
modeling material, a 3-D model of the brain emerged.
  Play-Doh and 3-D apps 
bring neuroscience  
 into psychiatry training
»
Research has found that 
adults retain only 5 percent 
of what they hear in 
lectures. So at a training 
conference, presenters 
taught neuroscience by 




Neuroscience can be over-
whelming, said Ross, one of 
three psychiatry educators 
spearheading the National 
Neuroscience Curriculum 
Initiative (NNCI), which aims 
to provide universities with 
the tools to teach neuroscience 
effectively. The NNCI provides 
a framework for neuroscience 
education, relying on expert 
neuroscientists and educators 
to generate content. The Play-
Doh brain, the first module of 
the initiative, is a kinesthetic 
learning exercise that serves as 
an introduction to the complex 
organ. “We’re going to start 
with something simple and fun,” 
said Ross. “Let’s play.”
The NNCI was created in 
response to the rising demand 
for better neuroscience educa-
tion in psychiatry. Historically, 
a deep divide has existed be-
tween neuroscience’s biological 
approach to the mind and the 
more traditional—and humanis-
tic—psychiatric perspective. In 
the past, neurobiological find-
ings have not readily translated 
into patient care, but techno-
logical advances over the last 
two decades have the potential 
to revolutionize both our under-
standing of psychiatric illness and 
the development of new treat-
ments. Advances in neuroimaging 
allow physicians to see healthy 
and abnormal brains in action, 
and advances in genetics have 
allowed researchers to identify 
rare genetic variants that contrib-
ute to such neuropsychiatric dis-
orders as Tourette syndrome.
Surveys conducted at 
Stanford and Georgetown found 
that psychiatry residents over-
whelmingly agreed that they 
needed better training to trans-
late those advances into clinical 
practice. Still, only a handful of 
universities, Yale among them, 
have comprehensive neurosci-
ence education programs.
One of the barriers to incor-
porating neuroscience into 
psychiatric training is the dif-
ficulty in teaching the subject 
effectively. Graduate medical 
education traditionally follows 
a lecture-intense format—a 
limited approach, according to 
Ross. “The literature on adult 
learning is that less than 5 per-
cent of what’s presented in a 
lecture setting is retained, and 
even that, I think, is wonder-
fully generous,” he said. “There 
would be a tragic irony if we, as 
the psychiatrists and neurosci-
entists who are studying how 
adults learn, failed to take that 
into account in the way we’re 
teaching our trainees.”
Melissa P. Arbuckle, M.D., 
Ph.D., associate professor of 
clinical psychiatry and the 
associate director of resident 
education at the Columbia 
University College of Physicians 
and Surgeons, and chair of the 
2014 BRAIN conference, teamed 
up with Ross and Michael J. 
Travis, M.D., associate professor 
of psychiatry at the University 
of Pittsburgh and director of 
Residency Training at Western 
Psychiatric Institute and Clinic 
at the University of Pittsburgh, 
to develop the BRAIN confer-
ence program—“Neuroscience: 
Why, What, and How to Teach 
It”—around novel ideas for 
ways to teach neuroscience. 
They dropped the traditional 
keynote lectures, opting for 
a workshop-driven day filled 
with new experiential learning 
approaches to neuroscience  
that other program directors 
could test at the conference  
and then incorporate into their 
own programs.
It worked. In the weeks 
immediately following the 
conference, the NNCI organiz-
ers began receiving positive 
feedback from programs around 
the country that had already 
implemented the Play-Doh exer-
cise. Other modules developed 
for the BRAIN meeting included 
an integrative case conference, 
which explores a case from 
biological, psychological, and 
social perspectives; a trans-
lational neuroscience module, 
in which participants look at 
cutting-edge clinical neurosci-
ence research and discuss how 
those advances could reshape 
psychiatry; and a module called 
Talking Pathways to Patients, 
in which participants role-play 
physician-patient interactions 
using a laminated card with 
images from the 3-D brain app 
to explain to a patient the neural 
systems underlying a disorder.
“Building on this success, we 
wanted to formalize a structure 
for continuing this work on a 
broader scale,” said Ross. He 




























the real peggy bia
Will the real Peggy Bia 
please stand up? Four 
students who played Bia 
in second-year shows 
reprised their roles at  
a reception in June,  
as faculty, alumni,  
and students offered 
hilarious and affection-
ate remembrances.
Photo gallery, as well  
as other online-only 
content, can be found 
on our home page at 
yalemedicine.yale.edu.
»
Passing of the torch in 
clinical skills education
A Greek inscription carved 
into the stone face above the 
entrance to the Sterling Hall of 
Medicine translates: “Those  
having torches will pass them 
on to one another.”
“It’s something Plato said,” 
said Margaret J. Bia, M.D., 
FW ’78, known for her tena-
cious personality, her Brooklyn 
accent, and her contributions 
to the clinical skills education 
of more than three decades of 
School of Medicine graduates. 
According to Bia, the clinical 
skills program, with approxi-
mately 140 faculty members 
who educate the next generation 
of physicians, exemplifies the 
value extolled by Plato. This year 
she’s passing on the torch.
Bia is retiring from medical 
education, though she’ll continue 
as a senior transplant nephrolo-
gist at Yale-New Haven Hospital. 
Jaideep S. Talwalkar, M.D., HS ’04, 
assistant professor of medicine 
and of pediatrics, will take over 
just as the medical school pre-
pares to implement a redesign of 
the curriculum. Talwalkar will 
direct the clinical skills program 
at large, ultimately determining 
how it will fit into the new cur-
riculum that emphasizes early 
clinical experience, an integration 
of the basic sciences and clinical 
medicine, and a restructuring of 
the clerkships. “With the cur- 
riculum redesign, we’re going  
to have to remake what the clini-
cal skills program looks like,”  
said Talwalkar. 
Barry J. Wu, M.D., clinical pro-
fessor of medicine, will run the 
clinical tutor program.
Bia has been the face of the 
clinical skills program at Yale 
for the last 15 years. When she 
took over in 1998, the program 
was heavy on didactics and 
light on practice, but under her 
leadership that all changed. 
“Dr. Bia has really changed the 
landscape entirely,” said Nancy 
R. Angoff, M.P.H. ’81, M.D. ’90, 
HS ’93, associate dean for stu-
dent affairs.
Historically, the first two 
years of medical education at 
Yale had focused on the basic sci-
ences, and until the 1980s, clini-
cal skills education began at the 
end of the second year. Students’ 
only clinical training before then 
was a physical diagnosis course. 
In the 1990s, faculty added ses-
sions on interviewing and patient 
communication, and started the 
tutor program. Today, clinical 
skills education begins before 
students even arrive at Yale, with 
the psychosocial communica-
tion curriculum run by Paul D. 
Kirwin, M.D., associate professor 
of psychiatry. Essays that stu-
dents write during that curricu-
lum influence the content of the 
clinical skills program, which is 
overseen by Barbara Hildebrand, 
the program manager.
Bia arrived at Yale in the mid-
1970s as a transplant special-
ist. Teaching had always come 
naturally to her, but she never 
imagined that she would have a 
seminal role in the formal edu-
cation of medical students. Her 
to house the modules and 
their content, where programs 
across the country or the globe 
could access the materials and 
implement them into their 
own neuroscience programs. 
“They’re thinking past their 
own institutions,” said Joyce 
Y. Chung, M.D., the program 
director of the National Institute 
of Mental Health (NIMH) clinical 
research training program, who 
saw the potential of the initia-
tive at the BRAIN conference 
and advised the group on their 
NIMH grant application. “When 
I saw what they had done with-
out funding, I could only imag-
ine what they could do with 
funding,” said Chung. In June 
of this year the group received a 
supplementary education grant 
of about $450,000.
The team created teaching 
guides for each module so that 
anyone without a background in 
neuroscience can feel comfort-
able teaching it.
Programs at Yale, Columbia, 
and Pittsburgh, which provide 
the framework for the NNCI, are 
at the leading edge of trends in 
psychiatry training. “At present, 
these advances in neuroscience 
education are a matter of pas-
sion for those involved,” wrote 
Mayada Akil, M.D., professor 
of psychiatry and vice chair 
for education at Georgetown, 
and her co-authors in an April 
2014 commentary in Academic 
Psychiatry. “We hope that in 
five to 10 years they will become 




a third-year M.D./Ph.D. student. 
“The success of the program is 
reflective of that.”
Talwalkar hopes to build 
upon that success in the pro-
gram in the future by beginning 
clinical learning even earlier, 
getting residents more involved 
in medical student teaching, and 
having students work within 
interprofessional care teams.  
“I don’t look to be replacing [Dr. 
Bia] in any way,” said Talwalkar. 
“I look to be building on what 
she’s already put in place.”
—Kate Wheeling
primary care internal medicine 
residents when Bia invited him to 
do the same for medical students. 
Patient-centered interview-
ing allows physicians to obtain 
biological, psychological, and 
social information and to create 
a more holistic description of a 
patient. According to Fortin, it 
can increase diagnostic accuracy 
as well as professional satisfaction 
among physicians, and decrease 
the risk of burnout and malprac-
tice suits. “I think there’s a rich 
tradition of humanistic care at 
Yale, and it was part of the infor-
mal curriculum,” said Fortin. 
“[Dr. Bia] brought it front and cen-
ter into the formal curriculum.”
To further improve physician-
patient communication skills, Bia 
brought on Matthew S. Ellman, 
M.D., associate professor of medi-
cine. Ellman, director of Medical 
Student Palliative and End-of-Life 
Care Education, teaches the stu-
dents how to communicate with 
patients at the end of life. “This 
isn’t considered one of the tradi-
tional medical skills, like taking 
a medical history or performing a 
physical exam, but she recognized 
that this is a skill that all medical 
students at Yale should get before 
they graduate, because no mat-
ter what specialty they go into, 
they’re going to, from time to 
time, be faced with patients that 
they can’t cure,” said Ellman.
“There’s something that’s just 
Dr. Bia that you can’t replace. You 
can’t really describe how much 
she cares about the program, but 
you can tell how much she cares 
about it,” said Samuel Sondalle, 
Margaret Bia has been a 
leader in medical educa-
tion, particularly in the 
teaching of clinical skills, 
since she arrived at Yale 
more than 30 years ago. 
“The skills program is 
where students learn the 
art of medicine,” she said.
love of medicine and doctoring 
led Bia to grow the clinical skills 
program into what it is today—a 
program that includes 44 skills 
sessions and 44 clinical tutorials 
in the first two years, 10 addi-
tional sessions for advanced skills 
training in the third and fourth 
years, a tutorial program, and 
sessions on LGBTQ issues, hospice, 
observation skills, and more.
“The skills program is very 
much where [students] learn the 
art of medicine,” Bia said. Much 
of that learning takes place in 
the tutorial program, in which 
a seasoned physician partners 
with four incoming students.  
Bia expanded and standardized 
the weekly tutor-student meet-
ings that take place through-
out the first and second years, 
ensuring that students and 
tutors get the most out of each 
session by outlining the goals 
and objectives.
According to Wu, the men-
toring relationship between 
students and tutors sets Yale’s 
program apart. “The longitudinal 
relationship is something that’s 
really celebrated here,” he said.
“I always wanted Yale to be 
as known and famous for medi-
cal education as it is for science 
and research,” said Bia. She 
assembled a dream team of clini-
cal educators that created the 
program as it is today. “It is not 
my program—it is the team’s 
program,” said Bia.
Auguste H. Fortin VI, M.D., 
M.P.H., associate professor of 
medicine, was teaching patient-














Educating the educators 
on Med Ed Day
How two Iranian  
doctors landed in jail for 
treating HIV/AIDS
Big data rule on  
Student Research Day
Full stories and event 
photo galleries, as well 
as other online-only 
content, can be found 
on our home page at 
yalemedicine.yale.edu.
»
Satiety hormone may have 
role in treating diabetes
With a name that derives from 
the Greek word for “thin,” the 
leptin hormone regulates the 
amount of fat stored in the 
body by controlling the feeling 
of hunger. It was discovered in 
1994, with high hopes that it 
would provide a groundbreaking 
treatment for a growing national 
epidemic of obesity. After an 
extensive clinical trial, those 
hopes were dashed.
Since that first study, the 
“satiety hormone,” as leptin is  
known, has proved useful 
in other ways. A team led by 
Gerald I. Shulman, M.D., Ph.D., 
the George Cowgill Professor of 
Medicine (Endocrinology), pro-
fessor of cellular and molecular 
physiology, and a Howard 
Hughes Medical Institute inves-
tigator, found that leptin could 
treat lipodystrophy, a condition 
common in HIV patients. The 
disease redistributes body fat in 
atypical ways, removing it from 
such areas as the arms, legs, and 
face and depositing it in the 
abdomen or the back of the neck. 
Leptin gained FDA approval for 
treatment of lipodystrophy in 
April of this year.
Now, on the 20th anniver-
sary of the discovery of leptin, 
Shulman and colleagues have 
found another potential use for 
the hormone. In a study pub-
lished in June in the advance 
online publication of Nature 
Medicine, the team reported that 
treatment with leptin reverses 
hyperglycemia, or high blood 
sugar, in rats with poorly con-
trolled type 1 and type 2 diabetes.
Like obesity, diabetes is one 
of the most common chronic 
conditions in the United States, 
affecting nearly 30 million 
Americans. Despite currently 
available treatments, many 
patients still struggle to control 
the high blood sugar levels that 
characterize the disease and 
result in complications, includ-
ing heart disease and blindness. 
According to Shulman, previous 
studies had shown that leptin 
lowered plasma glucagon, a hor-
mone that raises sugar levels in 
the bloodstream, producing the 
opposite effect of insulin. Using 
methods including noninvasive 
nuclear magnetic resonance 
(NMR) spectroscopy, a tech-
nique pioneered by Shulman in 
the study of diabetes, his team 
studied why this was happen-
ing. “We came to a very different 
conclusion,” Shulman said.
The team showed that instead 
of having its effect mostly 
through plasma glucagon, leptin 
reduced blood sugar in the rats 
by inhibiting a major neuroendo-
crine pathway, the hypothalamic- 
pituitary-adrenal axis. This  
interaction of three glands con-
trols the body’s reaction to stress 
and regulates other body pro-
cesses including digestion, energy 
storage, and metabolism. Further, 
the team found that leptin did 
in fact reduce plasma glucagon, 
but much later in the course of 
the treatment than through the 
newly discovered pathway.
Shulman, who is also co-
director of the Yale Diabetes 
Research Center, noted that 
though typical cases of diabetes 
can be successfully treated with 
insulin, “some cases are still dif-
ficult to control, and it may be in 
that subset that leptin therapy 
might be useful.” 
Leptin treatment for lipodys-
trophy made a very successful 
leap from rodent to human, said 
Shulman, who hopes the same 
is true in the case of diabetes 
treatment. “Clearly, leptin has 
been shown to be efficacious in 
patients with severe lipodys-
trophy and has made a great 
improvement in quality of life,” 
he said, “and now the question 
is whether it might be beneficial 
in patients with poorly con-
trolled type 1 and type 2 diabe-
tes.” Shulman and his team are 
currently working to develop a 
clinical trial of leptin in human 
diabetes patients.
Though these are “still early 
days,” Shulman said, “we are 







Researchers at the School of Medicine 
can reconstruct images of human 
faces based on fMRI readings of 
what’s embedded in our brains. Alan S. 
Cowen, a Yale undergrad at the time, 
postdoctoral fellow Brice Kuhl, Ph.D., 
and their advisor Marvin M. Chun, 
Ph.D., professor of psychology, cre-
ated a library of subjects’ responses 
to hundreds of pictures of faces. 
When subjects saw new faces, the 
researchers reconstructed what the 
subjects were viewing by comparing 
the scans to a mathematical model 
based on that library of responses. 
Cowen believes that as the accuracy 
of these reconstructions increases, 
they could be applied to research 
on how autistic children respond to 
faces. The research was published in 
Neuroimage in March.
 MY COUNTRY,  
 MY MICROBES
The microbes on your hands could 
reveal where you live, according to 
work by Yale researchers published 
in May in Microbiology. Analysis of 
bacteria on the hands of women 
in Tanzania and the United States 
showed that U.S. participants had 
more distinct species, while women 
in Tanzania had 11 times more bac-
teria per square centimeter of skin. 
The findings reinforce the role of the 
environment in the development of 
the microbiome. “How and where 
we interact with the environment 
affects our skin microbiota—which, 
for hands, can vary dramatically 
between groups,” said Jordan Peccia, 
Ph.D., professor of environmental 
engineering and the project’s princi-
pal investigator.
At the height of the Ottoman 
Empire—16 generations ago— 
a single individual passed on a 
genetic mutation that still afflicts 
Turkish children with a rare neuro-
degenerative disorder. In the  
April 24 issue of Cell, researchers 
identified a mutation in a gene 
involved in tRNA metabolism as the 
cause of the disorder that results 
in intellectual disability, seizures, 
delayed motor development, and 
atrophy in several regions of the 
brain. “By dissecting the genetic 
basis of these neurodevelopmental 
disorders, we are gaining funda-
mental insight into basic physio-
logical mechanisms important for 
human brain development and 
function,” said Murat Günel, M.D., 
HS ’98, Nixdorff-German Professor 
of Neurosurgery and study co-
author. “We learn a lot about 
normal biology by studying what 
happens when things go wrong.”
 FROM THE OTTOMAN EMPIRE,  
A GENETIC MUTATION PERSISTS
WALKING KEEPS SENIORS MOBILE
Walking as little as 20 minutes  
a day can keep older adults moving  
independently, according to Yale  
researchers. The Lifestyle Interventions 
and Independence for Elders Study 
evaluated 1,635 sedentary men and 
women aged 70 to 89 who were at 
risk for mobility disability. The clini-
cal trial, published this May in JAMA: 
The Journal of the American Medical 
Association, found that participants in 
a moderate-intensity physical activity 
program saw an 18 percent reduction in 
the risk of disability compared to par-
ticipants in a health education program. 
“Maintaining independence for older 
adults is both a public health and a 
clinical priority, and modifying lifestyle 
is an important approach to maintain-
ing independence,” said Thomas M. Gill, 
































































a collection of recent  
scientific findings
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AFTER A DAY OF SAILING, SW IMMING, AND JOGGING at his vaca-
tion home on Campobello Island in 1921, 39-year-old Franklin Delano 
Roosevelt went to bed early and suffered chills throughout the night. By 
the end of the next day, his legs were paralyzed from polio, and he never 
walked unaided again. Yet 11 years later he won the first of four presiden-
tial elections, and went on to become the longest-serving president of the 
United States. He reshaped American politics, brought the nation through 
the Great Depression, implemented the New Deal, and led the Allies to 
victory in World War II.
How many of us could persevere in the face of a crippling disease, let 
alone lead a troubled nation and world? Some of us can’t even sleep at 
night for stressing about our daily lives. Others, however, easily recover 
from natural disasters, terrorist attacks, and combat. “It’s about the sto-
ries people tell,” says psychiatrist Charles A. Morgan III, M.D., FW ’01, 
“And some people do more storytelling in their heads than others.”
As we set out to explore the theme of resilience for this issue of Yale 
Medicine, we learned that it comes in all different forms. We look at a 
woman’s recovery from a stroke and a dancer who overcame a career- 
ending injury and now cares for other dancers. Microbiologists describe 
how microbes survive not as individuals, but as populations. Child  
psychiatrists help children who have confronted violence. And faculty 
and students describe moments in their lives that led them to dig deep 
into their own stores of resilience.
resilience
Recovering from injury 
to body or mind.
 Yes, you can cope
  The epigenetics of child abuse 
  How children rebound from their worst nightmares 
  Why our bodies, and brains, bounce back
  Dancing through pain
  Resilience defined
  How two physicians deal with their own illnesses




















As many as 5.5 million children, 
such as these students in class at 
a makeshift camp for displaced 
people in Atmeh, Syria, have been 
affected by the ongoing civil war 
there. Psychiatrists have found 
that the human psyche is resilient 
and that people can recover 




 Yes, you can cope
  We are more resilient than we think,   
 according to psychiatrists who study  












Yes, you can cope
—but when Steven M. Southwick, M.D., the Glenn 
H. Greenberg Professor of Psychiatry, PTSD, 
and Resilience, worked with people who’d been 
through wars and famines, earthquakes and  
hurricanes, violent crime and terrorism, or some-
thing more mundane like losing money or going 
through a divorce, he discovered that most people 
are far stronger than they had ever imagined.
  Life is often  
something less  
 than the proverbial  
  bed of roses
watch The Exam Room: Resilience 
and the Optimistic Outlook  
(with Steven M. Southwick, M.D.)  
at youtube.com/YaleMedicine
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“Almost everyone experiences a significant traumatic 
event—a serious accident; the loss of a loved one, job, or 
home; assault or rape; a natural disaster; or something 
worse—yet most of us make it through and sometimes 
even grow stronger,” said Southwick, one of a number 
of researchers at Yale and elsewhere who are looking at 
resilience, the human characteristic that helps us make 
our way through life.
Resilience is an easy concept to understand but a hard 
one to nail down with scientific precision. It has proven 
hard to study, and little is known about it. There are only 
hints of biochemical markers, so in their absence, the 
American Psychological Association defines resilience as 
“adapting well in the face of adversity, trauma, tragedy, 
threats, and even significant sources of stress—such as 
family and relationship problems, serious health prob-
lems, or workplace and financial stresses.” In a sense, it’s 
similar to how an engineer would define resilience in a 
material: substances that bounce back to their original 
shapes when stressed. But in humans, there’s often an 
additional wrinkle. Think of a green twig that bends in 
a gale but doesn’t break. After the wind dies down, the 
twig not only survives but also continues to grow.
Southwick and colleague Dennis S. Charney, M.D., 
HS ’81, a former Yale professor who is now dean of Icahn 
School of Medicine at Mount Sinai Hospital in New York, 
recently pooled their insights in a book titled Resilience: 
The Science of Mastering Life’s Greatest Challenges. It’s 
a look at some of the most resilient folks on the planet, 
from POWs to survivors of 9/11, which examines the lat-
est research—a good deal of it being done at Yale—about 
what goes on in their brains. The book also explores key 
characteristics—which can be learned through good 
coaching and steady practice—that help people roll with 
the punches.
“In interviewing these extremely resilient people, 
we kept noticing the same factors coming up again 
and again,” said Southwick—everything from realistic 
optimism, the ability to face one’s fears, and a strong 
moral compass, social support network, and spiritual 
sense, to mental and physical fitness, the availability of 
resilient role models, psychological flexibility, and skill 
in finding purpose and meaning.
Underlying these hallmarks is the right kind of neuro-
physiology, the components of which a number of Yale 
researchers, Southwick among them, are uncovering.
Charles A. Morgan III, M.D., FW ’01, associate 
clinical professor of psychiatry, for example, studies 
members of the military’s elite special operations force. 
“Many people try out for special ops, but most don’t get 
in,” said Morgan. “That selection process is a funnel.”
After some 20 years of working with special ops sol-
diers, Morgan notes that one factor has become abundantly 
clear. “These people are different biologically, psychologi-
cally, and physiologically from the average person in the 
general military and civilian populations,” said Morgan. 
“They’re experts in resilience. They have a tough, tough job 
that exposes them to constant stress and almost unimagi-
nable trauma, and yet they’re so well suited by tempera-
ment and training to the work that the risk of untoward 
psychological side effects is significantly reduced.”
The rate of post-traumatic stress disorder (PTSD) 
among soldiers in general is, not surprisingly, higher—
between 12 and 15 percent, according to Morgan—than 
the 8 percent found in the civilian population, but in 
special ops, it’s remarkably low: between 1 and 2 percent. 
“This is a paradox, but we’re beginning to understand 
what’s going on,” he explained.
The brain is constantly under stress, but most of the 
time and in most people, it’s also perfectly capable of 
handling the situation, after which it damps down the 
stress circuitry. One tool is a calm-restoring brain chemi-
cal, neuropeptide Y (NPY), which is released alongside 
the brain’s alarm molecule, norepinephrine. “We’ve 
found that special ops soldiers have the capacity to 
release greater amounts of NPY than is typical, and this 
can blunt the negative impact of norepinephrine and 
other stress hormones,” said Morgan. “We’ve also shown 
that these people have higher levels of another stress-
protecting neurochemical called DHEA, and we suspect 
there are other important molecular differences as well.”
There is certainly a genetic component at work here. 
One of the most compelling studies to examine the gene/
environment interaction is research by Joel Gelernter, 
M.D., a Foundations Fund Professor of Psychiatry and 
professor of genetics and of neurobiology. Four years 
ago, in the journal Depression and Anxiety, Gelernter 
and his colleagues reported on more than 600 adults 
who’d been in the paths of the unusually severe group of 
hurricanes that pummeled Florida in 2004. They found 
a twofold increase in a condition known as generalized 
anxiety disorder (GAD), and among the GAD sufferers, 
there was an almost fourfold increase in the occurrence 
of a gene variant linked to lowered production of NPY.
“We all arrive on the scene different,” said Morgan. 
“There’s genetic variability, so when life comes your 
way, there’s a differential impact.”
A growing body of research shows, however, that 
nonstop, uncontrollable stress is universally problem-
atic. “Higher exposure to adverse life events is related 
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to a reduction in brain volume in the regions important 
to executive functions, such as reasoning, memory, 
emotional regulation, and perception,” said Rajita 
Sinha, Ph.D. ’92, a Foundations Fund Professor of 
Psychiatry as well as director of the Yale Stress Center, 
which studies the neurophysiology of stress and ways 
to deal with it. “Not having any stress in your life is not 
a good thing,” said Sinha, echoing a well-known quote 
by stress research pioneer Hans Selye that “the absence 
of stress is death.”
Fortunately, human evolution has endowed us 
with the ability to adapt to the many stressors we face. 
There’s increasing evidence from animal studies, noted 
Sinha, that recovery is possible, with rats and mice 
regrowing stress-damaged connections and regain-
ing lost deficits in such key areas as working memory. 
“During a very stressful period we might be unable to 
remember the plots of movies and find ourselves more 
easily distracted,” she said. “But we have developed a 
wide variety of coping mechanisms in the brain that 
enable us to avoid damage, learn from stress, and not 
only keep going but also to grow.”
While there’s no single recipe for resiliency, Sinha 
explained, there are universal elements that enable 
people to weather the storms and recover afterward. 
“Social support, keeping your basic needs well regu-
lated, drinking plenty of water, eating right, getting 
enough sleep, staying away from alcohol and other 
drugs, and regular exercise—these are critical,” she 
said, adding that overcoming stress can be difficult. 
“People need help, and often they lose a lot or hurt 
badly before transformation can occur.”
There are also medications—antidepressants and 
antianxiety drugs among them—that can help in 
recovery, and there are a variety of therapies aimed 
at enabling people who’ve been through trauma to 
get better. “It takes real guts to confront this,” said 
Southwick. He has used a technique called logo-
therapy—it’s modeled after psychiatrist and Holocaust 
survivor Viktor Frankl’s “healing through mean-
ing” insights—with chronic PTSD sufferers at the VA 
Connecticut Healthcare System in West Haven. “We 
work to find a way for each vet to participate in some 
kind of meaningful community service, say, for the 
homebound to serve meals to elderly shut-ins, or vets 
who are distressed about kids to work with trauma-
tized youngsters in schools. This is important because 
altruism is strongly associated with resilience and 
can generate meaning from adversity, which can be a 
source of tremendous strength.”
Yes, you can cope
Nietzsche declared that “he who has a ‘why’ to live 
for can endure almost any ‘how’,” and many trauma suf-
ferers find ways of turning their ordeals into meaningful 
action plans. Despite his almost lifelong imprisonment, 
Nelson Mandela found a way to forge an end to apartheid 
in South Africa. Jerry White, a Brown University under-
graduate who lost his leg to a land mine in Israel, helped 
spearhead a Nobel Peace Prize-winning organization 
aimed at banning land mines. Parents of children mur-
dered in the Sandy Hook school work to support efforts 
aimed at curbing gun violence, and people affected by 
trauma find that trying to help others cope with some-
thing similar can give meaning to their lives—and both 
ease pain and turn it into personal and societal progress.
Southwick has a coping strategy that combines a 
number of resilience techniques. He is always looking 
for ways to get stronger and be more resilient, which 
often means “trying to learn from the many role models 
we have had the privilege to interview. … I’ve learned to 
meditate and I really like to exercise, so Dennis Charney 
and I decided to challenge ourselves by entering a 
90-mile three-day kayak race in upstate New York.”
After less than an hour of paddling, Southwick 
was in agony. He hadn’t trained enough, and his neck 
and shoulders were hurting. “I thought I’d made a 
huge mistake and that I’d have to drop out, but then I 
remembered that I’d entered this event as an experi-
ment in a meditation technique known as mindful-
ness—a way to ignore  all those internal discussions 
you didn’t actually choose to have and focus intensely 
and nonjudgmentally on the moment.”
The technique, which can help restore a sense of 
control and tamp down overactive fear circuits, has 
recently been introduced as an alternative or comple-
mentary treatment for PTSD, and while Southwick felt 
more than a little discomfort throughout the grueling 
race, reorienting his thinking helped ease his muscular 
pain. In short order, he began to enjoy the kayak trip 
through exquisite Adirondack scenery.
Southwick and Charney didn’t win the race. But 
by practicing what they’d long been preaching, they 
managed to finish, resilient to the core. “It was very 
liberating,” said Southwick. Six weeks later, once the 
inflammation in his shoulders had subsided, he was 
again able to pick up a kayak paddle. /yale medicine
Bruce Fellman is a freelance writer in North Stonington, Conn.
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 The epigenetics  
of child abuse 
C H I L DR E N W HO S U F F E R  abuse, neglect, or trauma often 
develop depression and other psychiatric illnesses. As adults, 
they have a greater incidence of medical illnesses, including 
cancer, cardiovascular disease, and diabetes. But then again, 
many such children escape those dire consequences. What 
explains who succumbs and who rebounds?
Part of the answer may lie in genet-
ics, and the genetic predispositions 
of children who show resilience 
and those who don’t. But part of it 
may also lie in epigenetics, or how 
experiences influence gene activ-
ity. Epigenetic changes don’t alter the 
DNA in a gene, but rather how a gene 
is expressed. A common epigenetic 
change involves the addition of methyl 
to the chromatin structure around a 
gene, which typically suppresses 
the gene. Different life experiences 
can increase or decrease methylation 
Gelernter, M.D., a Foundation Fund 
Professor of Psychiatry, and profes-
sor of genetics, and of neurobiology, 
she compared epigenetic changes in 
96 children with a history of early 
adversity and 96 children without 
such a history. The researchers  
focused on differences in the 
methylation marks in the genomes 
of these children. 
“Based on animal studies else-
where looking at the effect of 
maternal neglect, we expected to 
see epigenetic changes affecting 
genes involved in the brain’s stress 
response,” she said. “We were sur-
prised to see them across the entire 
genome, not only in genes implicated 
in mental health and psychiatric 
disorders, but also in cardiovascular 
disease, diabetes, obesity, and can-
cer—all health problems long associ-
ated with early adversity.”
Epigenetic changes are long term, 
and these changes may be passed 
down to children and grandchil-
dren. But the effects of adverse 
childhood experiences don’t have 
to be permanent, Kaufman said. 
The concept of a “critical period” in 
which a brain pathway becomes 
fixed has given way to a “sensitive 
period” when the brain is more  
susceptible to environmental influ-
ences but retains some plasticity.  
In animals, environmental enrich-
ment has reversed deleterious brain 
effects mediated by epigenetic 
changes caused by early deprivation.
“However, to show such reversal 
in humans,” Gelernter said, “we 
would have to study the same indi-
vidual over time to see if the epige-
netic markers revert in people who 
have less pathological outcomes.”
“There’s reason to be optimistic 
that we could intervene and amelio-
rate the consequences of early child-
hood adversity,” Kaufman said.
—Cathryn Delude
through mechanisms researchers are 
still trying to understand.
“It’s exciting to realize that 
genetic effects are not fixed and 
how dynamic the interactions are 
between genes and the environ-
ment,” said Joan Kaufman, Ph.D., 
associate professor of psychiatry. 

















 How children rebound  
from their worst nightmares
“I M AG I N E T H AT YOU A R E 10 Y E A R S OL D, or 15, and you 
awake to the sound of your parents in a heated argument. Then 
imagine that the sounds turn to screaming as you enter the 
room where your mother is being beaten and your father is 
threatening to kill her. …  Is your heart rate up? Are you actively 
trying to push away the images?” asks Steven Marans, M.S.W., 
Ph.D., professor of psychiatry and director of the Childhood 
Violent Trauma Clinic at the Yale Child Study Center.
Every year, Marans says, millions 
of children in the United States 
are exposed to community and 
domestic violence, natural and 
human-made disasters, and medi-
cal emergencies. “A traumatic 
event is the realization of your 
worst nightmare,” says Marans. 
“The worst has happened, and hap-
pened in a way that leaves one dys-
regulated and powerless.” Without 
help, too many children will be 
unable to fully wake up from the 
nightmare. Unable to recover, 
these children may suffer the scars 
of trauma over a lifetime.
Children with untreated 
trauma can grow up to become 
adults with a disturbing medley  
of mental and physical illnesses. 
But Marans and his colleagues 
at the Childhood Violent Trauma 
Clinic, Carrie Epstein, M.S.W.,  
and Steve Berkowitz, M.D. (now 
at the University of Pennsylvania), 
have developed a brief early-
intervention model. The Child 
and Family Traumatic Stress 
Intervention (CFTSI) is now  
helping children who have seen, 
heard, and felt too much.
As humans, we share a distinct 
set of fears: loss of life, limb, lucid-
ity, and love. Children are par-
ticularly vulnerable to traumatic 
events. They depend on adults to 
see them through stressful events 
until they develop the cognitive 
and psychological maturity to 
handle such situations on their 
own. One of the most powerful 
predictors of outcome after trauma, 
says Marans, is the degree of exter-
nal social support. Linda C. Mayes, 
M.D., FW ’85, the Arnold Gesell 
Professor of Child Psychiatry, 
Pediatrics, and Psychology in the 
Child Study Center, agrees that in 
order to be resilient, children need 
“to be protected and buffered from 
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overwhelming stress—to have 
adults who care.”
Unfortunately, children may 
not have the skills to commu-
nicate their traumatic reactions, 
and their caregivers may not rec-
ognize the symptoms. Moreover, 
many of the children at the great-
est risk of exposure to such trau-
matic events as domestic violence 
are often the least likely to receive 
support. One of the many ways 
the CFTSI aids in recovery is by 
bolstering communication and 
support between children and 
their parents or caregivers. The 
intervention teaches children how 
to talk about their mental and 
physical reactions to trauma and 
teaches caregivers to recognize 
when those reactions become 
symptoms of traumatic stress.
The CFTSI grew out of more 
than two decades of collabora-
tion between the Child Study 
Center at Yale and the New Haven 
Department of Police Service. The 
collaboration between police 
officers and mental health profes-
sionals has brought many at-risk 
children from urban and economi-
cally disadvantaged families who 
have been exposed to violence to 
the attention of clinical service 
providers. It fills the gap between 
existing acute responses deployed 
at the time of the traumatic event, 
and longer-term treatments 
designed to address trauma symp-
toms and disorders that are already 
established. In as few as five ses-
sions, the CFTSI can ease current 
suffering and symptomatology in 
children and prevent traumatic 
stress disorders from taking hold 
by returning a sense of control to 
both children and their caregivers.
Instead of leaving children 
alone with their traumatic terror 
and helplessness, a CFTSI-trained 
clinician coordinates with police, 
social services, and medical pro-
viders. They ensure safety while 
addressing post-traumatic reac-
tions that so often follow over-
whelming events. Over five to 
eight sessions, children and par-
ents or caregivers are helped to 
identify and verbalize symptoms 
in ways that increase commu-
nication with and support from 
caregivers. They also learn such 
techniques as focused breath-
ing, re-establishing routines, and 
recognizing what triggers post-
traumatic reactions, with the aim 
of regaining control of their minds 
and bodies. As symptoms decrease, 
a sense of safety and competence 
can return, while the traumatic 
threat to developmental progress  
is diminished.
Children who received CFTSI 
services were 65 percent less likely 
to develop PTSD three months 
after a potentially traumatic event 
than children who received a stan-
dard intervention. And after the 
CFTSI sessions, caregivers seem to 
be more in tune with the trauma 
symptoms as they present in chil-
dren. “CFTSI reduces the discrep-
ancy between reports of symptoms 
by both parents or caregivers and 
children,” said Marans.
In addition, the CFTSI serves as 
an assessment tool, helping clini-
cians identify children in need of 
further psychotherapeutic treat-
ment. While many children who 
receive CFTSI services experience 
significant reduction or resolu-
tion of post-traumatic symptoms, 
there are those children who 
will require longer-term trauma-
focused or other mental health 
treatment provided by the Trauma 
Clinic and other clinical services 
of the Child Study Center. This 
work, Marans said, is supported by 
the Substance Abuse and Mental 
Health Services Administration, 
and is being disseminated to men-
tal health clinicians and agencies 
around the country.
By capitalizing on a growing 
understanding of the factors that 
contribute to a healthy and happy 
human experience, the interven-
tion decreases the likelihood that 
trauma will be damaging to a child’s 
future. It restores to children and 
their caregivers the sense of control 
that they often lose after traumatic 
events. Trauma doesn’t have to lead 
to lifelong afflictions, according to 
Marans, “It’s not a fait accompli.”
—Kate Wheeling
watch Among the Traumatized  


















With the help of her daughter, 
Sarah, and husband, Chris, Helen 
Bolan recovered from a stroke 
caused by a rare condition that 
results in constriction of arteries 
in the brain. 
  Why our bodies,  
 and brains,  
  bounce back
        As soon as something breaks, tears,  
     or malfunctions within us, the instructions  
       in our cells begin to supervise repairs.  
         How this regeneration happens  
        and how it might be exploited  













with her husband, Chris, and their 10-year-old  
daughter, Sarah, at their home in Trumbull,  
Conn. Helen was about to comment on the ocean  
of hot sauce that Chris was pouring onto his  
stew, but the words wouldn’t come out. As she 
struggled to speak, it became clear that some- 
thing was seriously wrong. Chris dialed 911,  
and an ambulance rushed Helen to the hospital.
  On January 22, 2013,  
 Helen Bolan sat down to dinner
Why our bodies, and brains, bounce back













of strokes are ischemic,  
caused by a narrowing  
or blockage of  




of strokes are  
hemorrhagic, caused by  
bleeding in the brain
The average stroke lasts 
10 
HOURS
Every hour without  
treatment, the brain  
ages effectively by 
3.6 
YEARS
Stroke patients can’t  
compensate for the loss  
of brain cells by making new 
neurons, but they often  
recover some function  




a typical stroke goes untreated,  
a person loses …
A “decoy” for reversing 
the effects of stroke A protein in nerve cells—the neurite 
outgrowth inhibitor, or Nogo—inhibits the formation of new 
synapses. A newly discovered molecule that blocks the receptor  
and helps synapses to form may help stroke patients recover.  

















































While frightening, the episode was only a warning—an 
event known as a transient ischemic attack, or TIA. Often 
called mini-strokes, TIAs are temporary blockages of the 
arteries that feed the brain, causing stroke-like symp-
toms that last no more than 24 hours. Exactly two weeks 
later, almost down to the minute, Helen had another 
TIA. Sarah called an ambulance, and Helen watched her 
reflection in the mirror as paralysis overtook her right 
side. Helen’s doctors didn’t see anything on her initial 
brain scans to explain the attacks, but Helen had a his-
tory of migraines, and the intense headaches are known 
to present with TIA-like symptoms. After her second 
TIA, she started taking a migraine medication, and Chris 
and Helen hoped that her neurological woes were behind 
them. Helen went a full four months without another 
TIA. Then, on June 14, she had a stroke. 
“outstanding progr amming”
The body is a battlefield. It deals with insults and inju-
ries every day, from the sting of a paper cut to the mas-
sive damage that can occur during a stroke. Immune 
cells fight off infection, torn muscles recover, and bro-
ken bones mend. Even an organ as fragile as the brain 
can recover. Speech and motor function may return 
even after large swaths of brain cells perish during a 
stroke. “Almost all the people who have strokes recover 
some function between one week and six months,” 
said Stephen M. Strittmatter, M.D., Ph.D., the Vincent 
Coates Professor of Neurology, professor of neurobi-
ology, and co-director of Yale’s Program in Cellular 
Neuroscience, Neurodegeneration and Repair.
The human body and brain are designed to bounce 
back from injury. “Part of that robustness comes from 
the fact that the cells in our bodies have outstanding 
programming, and they can repair and reconstitute 
tissue and organ function even after an insult,” said 
Laura E. Niklason, M.D., Ph.D., professor of anesthesi-
ology and of biomedical engineering. To a large extent, 
the body heals on its own, but those natural healing 
mechanisms can falter or fail. Researchers at Yale are 
looking for ways to bolster the body’s ability to bounce 
back by studying the human body where it is most 
vulnerable—and where it is most resilient (see sidebar).
“Different tissues and organs have different degrees 
of resilience,” said Ruslan M. Medzhitov, Ph.D., the 
David W. Wallace Professor of Immunobiology and 
a Howard Hughes Medical Institute investigator at 
Yale. “What makes us really sick, and what can kill an 
organism, animal, or human, is when the most vulner-
able aspect of our physiology—the organs or tissues 
or processes that have least resilience—are affected 
enough to push them over the edge.”
The brain is especially sensitive, and so the body has 
developed a host of defenses to protect it from insults. 
A hard skull shields it from mechanical blows, and 
internal mechanisms maintain the supply of glucose 
and oxygen to the brain even at the expense of other 
tissues. “These mechanisms ultimately increase the 
resilience of the entire organism because they protect 
the weakest links in the system,” said Medzhitov.
None of those mechanisms can protect the brain 
from a stroke, but neurologist David M. Greer, M.D., 
Ph.D., hopes that a new application of an old technique 
can help to buffer the brain from stroke-induced injury. 
Greer, the Dr. Harry M. Zimmerman and Dr. 
Nicholas and Viola Spinelli Professor of Neurology 
and and professor of neurosurgery, is Yale’s principal 
investigator of a nationwide Phase II/III clinical trial 
to study the effects of induced hypothermia in limit-
ing brain damage during the acute phase of stroke. 
Induced hypothermia—lowering a patient’s body 
temperature to 91 degrees Fahrenheit—has been used 
for years in the operating room and, more recently, 
following cardiac arrest. The precise mechanism is 
unclear, but therapeutic hypothermia appears to allow 
the body—and the brain—to get by with less oxygen. 
Greer and his co-investigators believe cooling could 
prevent stroke-related damage in a number of ways: 
hypothermia slows the metabolic rate of cells, sta-
bilizes cell membranes, halts the release of harmful 
neurochemicals and enzymes, and reduces inflam-
mation. The investigators plan to test the technique in 
combination with tissue plasminogen activator (tPA), 
a naturally occurring protein administered during a 
stroke to dissolve blood clots in blocked vessels.
If the stroke team can prevent too much damage 
from occurring, the brain will take over its own heal-
ing. But often stroke victims don’t arrive at the hospital 
in time to receive such acute treatments as this one, 
according to Greer. Helen Bolan didn’t. 
Why our bodies, and brains, bounce back
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Of the many factors that influence the body’s ability to heal, age is 
perhaps the most critical. “The younger you are, the more resilience 
you have,” said Joseph A. Madri, M.D., Ph.D., professor of pathol-
ogy and director of education. As researchers have noted for more 
than three decades, the womb is a good place to heal. “If you look 
at cases of in utero surgery you’d be hard pressed to find surgical 
scars,” said Madri, who directs the undergraduate course “Biological 
Reaction to Injury.”
In all likelihood, some combination of the growth factors, im-
mune components, and stem cells in the uterus, plus the relative 
lack of biomechanical stress, allows not only the repair of fetal tissue 
but also its complete replacement. As a graduate student, Anjelica 
Gonzalez, Ph.D., an assistant professor of biomedical engineering, 
was intrigued by fetal regeneration and wondered how one might 
harness the regenerative capacity of fetal cells to promote healing.
Like her colleague Laura Niklason, M.D., Ph.D., professor of 
anesthesiology and of biomedical engineering, Gonzalez is looking 
closely at the elements involved in healing to find new ways to 
manipulate them in our favor. Her lab is investigating the chemical 
messengers that are active during fetal development for ideas that 
might lead to better treatment of severe burns in children. Niklason 
is pursuing a similar line of inquiry, with the aim of building better 
replacement blood vessels.
Gonzalez has focused much of her work on neutrophils, the im-
mune system’s first responders to a burn injury. These white cells follow 
a trail of chemical signals through blood and tissue to arrive at the sites 
of inflammation. Once there, they ingest dead and dying cells within the 
damaged tissue, along with anything else—such as microbes looking for 
a way into the body—that may hinder healing. But if neutrophils remain 
at wound sites for too long, they can interfere with healing.
The amnion, the membrane that surrounds the fetus, contains 
natural proteins that recruit neutrophils and other leukocytes to 
the site of a wound and then block that recruitment once the white 
cells’ job is done. Gonzalez is trying to identify those amniotic 
signals that initiate and then terminate the inflammatory response 
and replicate them in an artificial scaffold—a structure that mimics  
the extracellular matrix and supports the three-dimensional 
growth of tissue. Gonzalez’s scaffolds would allow for inflamma-
tion but prevent it from becoming chronic, so that the regenerative 
programming in human cells can take over: cells divide, new tissue 
is born, and the wound heals. That inherent programming is also 
what allows Niklason to grow blood vessels in the lab.
Blood vessels are inherently resilient. They expand and contract 
with each heartbeat, roughly 100,000 times a day. Ironically, how-
ever, the same mechanisms meant to protect blood vessels from 
stress and damage can also lead to their failure.
When patients have high blood pressure, the blood vessel wall 
resists that force by growing thicker. But as the inside of the vessel 
narrows, the pressure and the risk of either rupture or blockage 
increase. Surgeons can bypass the damage to an artery with a vessel 
graft—a section of transplanted or prosthetic blood vessel that redi-
rects blood flow around the damaged stretch of artery. Because veins 
are plentiful, they are a common source of grafts, but they aren’t built 
to withstand the same pressures as arteries. Synthetic grafts made of 
such plastics as Teflon are stronger, but they also fail over time.
Niklason is growing arteries from the body’s own smooth muscle 
cells instead. The cells are the seeds from which tissue will grow, but 
they need more than a Petri dish to grow into fully formed and func-
tional vessels. Niklason harvests smooth muscle cells from donated 
tissue, seeds the cells on a biodegradable scaffold, and exposes them 
to mechanical and chemical cues that induce tissue growth. These 
are not the exact instructions that the cells would have received 
from a naturally occurring extracellular matrix, but they’re close 
enough. “The biological system for regeneration is robust enough 
that we don’t have to get it exactly perfect,” said Niklason.
As the muscle cells proliferate, the degradable polymer mesh 
that guided their growth disappears and is replaced by connective 
tissue—an extracellular matrix laid down by the cells themselves. 
Before the grafts are implanted, the cells, which contain the major-
ity of the immunogenic cues, are removed, leaving behind a tube 
that will serve as a new artery.
Ideally, the graft will be repopulated by the host cells, which will 
produce their own mesh of protein-rich extracellular matrix. Over 
time the tissue will remodel until the graft that was implanted isn’t 
really there any longer: it has been completely replaced by host tis-
sue. “That,” said Niklason, “is regeneration in the truest sense.”
—Kate Wheeling
 Can resilience 
be engineered?
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af ter an insult,  the br ain rearr anges
Bolan didn’t know she’d had a stroke until four days 
following the event, during a regularly scheduled 
appointment with her doctors at Bridgeport Hospital. 
To Helen, the stroke was unlike her TIAs: she was 
groggy but fully mobile, and her trouble with words 
came on gradually rather than all at once. Her husband 
was out of town. There was no one to notice anything 
amiss. By the time she saw Greer, a lot of damage had 
been done. Her speech was significantly impaired—she 
knew what she wanted to say but words escaped her—
and her right side was weak and sore.
In August 2013, Greer diagnosed Helen with 
Moyamoya syndrome—an uncommon disease that causes 
the constriction of arteries in the brain. Looking at her 
brain scans, Chris and Helen could see the tissue that had 
been lost, and they saw the dark line of her carotid artery 
collapse as it curved into the left side of her brain. “It was 
quite startling,” said Chris. “[Her] brain was starving.”
To preserve her undamaged brain tissue, surgeons 
rerouted an artery to supply more blood and oxygen to 
her left hemisphere. After the surgery and months of 
rehab, Helen slowly recovered the functions she’d lost. 
But she’s not quite her old self. “I’m not as talkative as I 
used to be,” she said.
“There is a significant amount of recovery that hap-
pens naturally,” said Strittmatter. The brain doesn’t 
regenerate; it rearranges. One region of the brain can take 
on functions like speech and movement that were previ-
ously the province of regions now damaged by stroke or 
trauma. “So the function is moving,” said Strittmatter.
How this reconfiguration happens is something of a 
mystery, according to Strittmatter, though animal studies 
indicate that it’s likely to be some combination of changes 
in the wiring and biochemistry of synapses, the con-
junctions between nerve cells. While it is unlikely that 
the brain can make new nerve cells to replace those lost 
during a stroke, it can make new connections. Scientists 
can see this process unfold in mice. Using two-photon 
excitation microscopy to look inside the brains of living 
animals, they can watch single nerve fibers and their 
synapses change over time. After a stroke, new pathways 
and bridges around the damage can emerge from surviv-
ing axons. “Those new connections may make up for a 
dead neuron that was lost in a stroke or trauma,” said 
Strittmatter. But only up to a point; the more damage that 
is done, the fewer brain cells we have in reserve.
dissolving the neur al glue
“The ability to make new connections and rearrange  
connectivity drops as the brain develops,” said 
Strittmatter. As we enter adulthood, the brain starts 
making molecules that inhibit rearrangements, lock-
ing synapses into place like neural glue. Strittmatter’s 
lab is looking for ways to dissolve that glue selectively. 
Over two decades of research, his group has identified 
neurite outgrowth inhibitor, or Nogo, a molecule that 
inhibits the sprouting of new synapses, and has char-
acterized the receptor protein by which Nogo transmits 
its instructions. They have also found molecules that 
block that transmission by trapping Nogo and prevent-
ing access to the receptor. Testing in rats has identi-
fied compounds that enhance recovery from stroke 
without side effects. Strittmatter co-founded Axerion 
Therapeutics to develop medications based on these 
findings, though he says it will be 18 to 24 months 
before any drug candidates are ready for clinical trials. 
Such drugs would hold promise for patients like Helen, 
who don’t reach the hospital in time to receive the 
clot-busting agents that must be given no more than 
three to four hours after symptoms appear. By block-
ing Nogo’s inhibitory effects, the drugs could allow 
patients to make more neural connections and experi-
ence faster and more complete recovery not just from 
stroke but from any traumatic neural injury.
Even without drugs to enhance the plasticity of her 
brain, Helen regained nearly all of the function she had 
lost. The first sign that she had recovered came almost 
eight months after the stroke. “After the surgery, Helen 
got bored,” said Chris. Once her rehab assignments 
weren’t challenging enough to keep her engaged, she 
knew it was time to go back to work, and in April  
she returned to her job as an accountant. She still has 
trouble finding the right word sometimes, and her 
right side feels sore on occasion. “I know it could have 
been a lot worse,” said Helen. “I was very lucky in a  
lot of ways.” /yale medicine
Kate Wheeling was Yale Medicine’s 2014 writing intern.
Why our bodies, and brains, bounce back
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Much of the emphasis on resilience research and therapy centers 
on the individual—but according to Catherine Panter-Brick, D.Phil., 
professor of anthropology, health, and global affairs, societies can 
be better structured to “foster, rather than hinder,” the natural 
resilience of their citizens. Panter-Brick’s work in Afghanistan, 
Africa, the Middle East, the United Kingdom, and the United States 
offers insights into ways of “providing resources to people who 
are resourceful—helping them overcome dire circumstances and, 
when things get better, enhancing life opportunities rather than 
putting up barriers.”
One of the foundations of more-resilient societies is that they 
have in place the proper legal and economic structures that can 
expedite recovery well in advance of disasters. Achieving such 
macro-level transformations requires strong leadership, said 
Panter-Brick, who also works in the Child Study Center—but there is 
plenty that can be done without a Gandhi or a Mandela. She has been 
working on a program aimed at helping young fathers do a better 
job of rearing kids—which ultimately results in more-resilient dads 
and children. “We focus on men who’ve been involved in crime, and 
we’ve found that when they have fathered a baby, there’s a tipping 
point,” said Panter-Brick. “If we provide resources then—such as 
job training, housing assistance, and social support—we can change 
a young man’s trajectory and, in the process, use his resilience to 
bring about a better future for everyone.”
If engaged at the proper time with the right resources, other 
strong leverage points can help people do what most researchers 
feel is natural: bounce back, and in the best cases, grow. “I have a 
lot of faith in ordinary people and families,” said Panter-Brick.
—Bruce Fellman
 Building strong societies,  
one dad at a time
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An injury ended Mamie Air’s career 
as a dancer. Now she uses what 
she learned from her own injury to 
care for other dancers.
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Dancing through pain
W H I L E A S T U DE N T  at the School of Medicine, Mamie Air, 
M.D. ’09, was juggling her courseload with the demands of per-
forming ballet, jazz, and modern dance with Yale Dancers when 
she developed severe pain in her hip. Sitting on an exam room 
table at Yale-New Haven Hospital, she didn’t yet know that she 
would face surgery and the end of her dance career. Her urgent 
care doctor’s conclusion hit her, as it would any dancer, like a 
death sentence: “Well, obviously you’ve got to stop dancing.”
Since she began dancing at the age of 
5, Air had performed through nasty 
blisters, overused joints, and agoniz-
ing tendinitis. Serious dancers will 
not be surprised by this catalogue 
of miseries. “Dance is a culture of 
resilience,” said Cordelia Carter, M.D. 
’04, a sports medicine specialist at 
Yale Orthopaedics & Rehabilitation 
Services who has cared for dancers  
in the Boston Ballet. “Dancers are 
some of the physically strongest 
people I’ve ever worked with. There’s 
a lot demanded of them physically—
and repeatedly—and I think that’s 
where the mental toughness comes 
from. There’s a culture of pushing 
through pain.”
Air, a double board-certified 
and fellowship-trained physiat-
rist in sports and interventional 
spine medicine in California, now 
cares for dancers. Her patients, she 
believes, have an inherent resilience 
off seeing a doctor for as much as 12 
months, if they receive treatment at 
all. Air’s research, which has received 
national and international recogni-
tion, has also shown that fewer than 
20 percent of dancers’ injuries may 
be evaluated by a physician. “Many 
dancers will—at least initially—dance 
through the pain, self-treat, or seek 
help from a colleague.”
All this capacity for endurance 
would seem to add up to a classic 
picture of resilience. But what hap-
pens when a dancer can’t dance 
anymore? Air, whose Yale medical 
thesis explored the psychologi-
cal aspects of dance-related injury, 
says dancers face tremendous 
psychological distress when injured. 
“Pretty much all dancers know that 
ultimately they will retire from 
their dance careers. But you never 
actually think it’s going to happen 
to you. When it does, particularly if 
it is a forced or unexpected retire-
ment due to injury, you go through 
a grieving process, if not identity 
crisis,” Air said.
While some dancers may lose 
their way in this process, others,  
like Air, look for a silver lining. 
She won a Fulbright scholarship to 
learn more about caring for injured 
dancers at the Medical Centre 
for Dancers and Musicians in the 
Netherlands. During her residency, 
she co-founded the Seattle Dance 
Medicine free clinic, which offers 
free medical care to injured dancers. 
While no longer dancing at the 
performance level, Air continues to 
call upon the qualities she devel-
oped as a dancer. “My injury made 
me a better doctor. And for that,  
I am grateful.”
—Kathy Katella
fostered in highly demanding envi-
ronments. “From a very young 
age, there is an unusual emphasis 
on physical accomplishment of 
extremely difficult technique, both 
quantitatively and qualitatively, 
mental focus, self-control, and 
an aesthetic which defies normal 
human anatomy and physiol-
ogy,” Air said. “They function in a 
sport which demands diametrically 
opposed physical traits. They must 
be strong, yet flexible; muscular, yet 
skeletal; durable, yet delicate; and 
powerful, but gravity defying.”
Research has shown that up to 
97 percent of dancers experience 
injuries in a given year, Air said. It 
is not uncommon for dancers to put 
watch An Accident, a Broken Neck, Then 

















“There is no one ac-
cepted definition of 
resilience, but I think 
most of us would 
think of it as a bend-
ing, but not breaking, 
and bouncing back in 
response to adver-
sity—sometimes even 
growing. I think that 
another way to think 
about it is how adapt-
able we are and how 
flexible we are during 
difficult times, how  
we adjust.”
Pranay Sinha 
FIRST-YEAR RESIDENT // 
“When I’ve made mis-
takes, I’ve had to sit 
down and remind my-
self that this happens 
to everybody, and 
crying about it right 
now or letting it affect 
the rest of my day isn’t 
going to make things 
any better. So the only 
way I can deal with 
this is to keep moving 
and pay more atten-
tion to what I’m doing. 
And this is part of the 
greatness of medi-
cine. It forces you to 
become this stronger 
person who takes his 
work very seriously 




“If you don’t have 
stamina and resilience 
as a graduate student, 
you’re not going to 
graduate, because 
most experiments 
do not work. That’s a 
dirty little secret. Yes, 
you can learn through 
the do-not-work part, 
but the reality is that 
it’s not that you do a 
couple of experiments, 
figure 1, a couple of 
experiments, figure 2. 
… Most of the time, 
things don’t work,  
so science is all about 
resilience. If you  
don’t have that in  
you, you just couldn’t 
be a good scientist.”
Laura Niklason 
BIOMEDICAL ENGINEER // 
“They say that 
laboratory work is 
composed of good 
days and bad months. 
And I think that having 
a conviction that you 
can think your way 
out of problems and 
engineer your way 
to solutions is a big 
part of resilience in 
this field. … It took us 
18 years to get from 
the start of the [engi-
neered blood] vessel 
project to the first 
implant in man, and 
that’s actually making 
pretty good time.
“I was trying to 
finish up some key 
studies, some key 
proof-of-principle 
studies in pigs. This 
was like 15 years ago. 
I had nearly a year of 
culturing and ex-
perimental failures for 
reasons that it took 
me a very long time 
to figure out, and I 









BIOMEDICAL ENGINEER // 
“There was a person 
whom I admired sci-
entifically who told  
me that I had a poor 
work ethic and should 
get out of the field. …  
Every step of the way 
I’ve worked very hard, 
and to tell me that 
that’s the reason I 
would fail was demor-
alizing. I didn’t go to 
class for two days. … 
then I thought that if  
I don’t go, then I’m 
proving to him that 
I won’t work. I think 
that was the hardest 
time, for me to get up 
and go to school and 
go to lab.
“Three weeks ago 
a colleague was at 
Baylor University for  
a seminar and this  
guy was saying how 
I’m doing great work. … 
and it was him!”
Peter Jokl 
SPORTS PHYSICIAN // 
“I went to Yale, was on 
the track team. I was 
pretty good; I certainly 
wasn’t the best. You 
get injuries and you try 
to maintain a positive 
outlook, and during 
an injury you try to 
find ways that you can 
maintain your ath-
letic competence while 
healing. If someone 
injures an arm or a leg, 
I’ll tell them they’ve got 
three other extremi-
ties and their heart and 












































verance in the face of 
adversity. … When I 
was starting my career, 
my first NIH application 
received a score that 
is no longer obtainable 
because of the way we 
triage grants now. On 
a scale of 1 to 5, my 
application got a score 
of 5, which meant that 
if there were an infinite 
amount of money 
and nobody else was 
applying, my grant 




“Because I was grow-
ing up in communist 
Russia, there were 
all sorts of perturba-
tions on the way to 
attempting to perform 
studies and science. 
I was in graduate 
school during the eco-
nomic crisis when the 
country was breaking 
apart, when the econ-
omy was destroyed, 
transitioning from a 
communist economy 
to a market economy 
when resources 
were nonexistent for 
science. During that 
period it was almost 
impossible to perform 
any kind of science. 
Even literature was 
not available to read.
“You have to  
be resilient in that  
environment in order 
to maintain interest  
in science and not  




“I’m a C6 tetraplegic.  
I broke my neck 
snowboarding when I 
was 20 years old. I had 
to relearn how to walk. 
I had to relearn how to 
eat. … I’m able to walk. 
I’m able to touch type.  
My hands are rela-
tively functional but 
I don’t think I’ll do 
anything like surgery 
or things where I need 
fine motor skills and 
dexterity. I think I’m 
going to be a lot more 
focused on more in-
tellectual fields where 
you talk to patients 
and interact with 
them more that way.”
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 How two physicians deal  
with their own illnesses
PAU L K A L A N I T H I,  M.D. ’07,  was nearing the final year of his 
neurosurgery residency at Stanford when his weight started to 
drop, his back hurt, and he felt tired all the time. As the symp-
toms worsened, he suspected cancer. A CT scan revealed masses 
lacing his lungs and deforming his spine. In May 2013, Kalanithi, 
a 36-year-old who didn’t smoke, was diagnosed with stage IV 
non-small-cell EGFR-positive lung cancer. His first response 
was to prepare to die and to encourage his wife to remarry. But 
he quickly realized that coping meant making a commitment to 
living his life and values instead of resigning himself to dying. 
He began treatment with erlotinib and returned to work. Then 
Kalanithi and his wife, Lucy Goddard Kalanithi, M.D. ’07, chose 
to have a baby. “Having children was something we planned to 
do, and there was no reason not to continue living and achiev-
ing the things we wanted to achieve with whatever time I have 
left,” he explained. Elizabeth Acadia (“Cady”) Kalanithi was 
born on July 4.
Kalanithi and Christopher H. Lee, 
M.D., HS ’09, FW ’10, an associate 
research scientist in the Department 
of Emergency Medicine at Yale, both 
faced severe illnesses that radically 
affected their lives as well as their 
families. Both recognized that nor-
mal would no longer be what it had 
been, and both found ways to cope, 
with the help of friends and family.
Having seen families fall apart 
when faced with illness, Kalanithi 
made family a priority. “The ill- 
ness doesn’t just happen to the  
person,” he explained. “It happens 
to the whole family. It’s very  
important to be aware of how  
everyone is doing emotionally and 
how they are impacted by my  
illness.” As a result, he and Lucy 
have grown closer.
Over the past year, as Kalanithi 
battled a chronic cough, fatigue, 
excruciating back pain, and the 
effects of chemotherapy, friends 
and family have helped, doing 
everything from providing meals to 
running errands. But relinquishing 
self-reliance wasn’t easy. “We knew 
if we were going to do some of these 
life-affirming things, like having a 
baby, we would need lots and lots 
of help,” he said. “It’s a funny side 
of resilience to recognize that you 
are dependent on other people.” 
Accepting support became easier 
when Kalanithi saw how meaning-
ful it was for friends and family to 
offer their help.
For Kalanithi, resilience includes 
finding purpose. When his essay 
“How Long Have I Got Left?” was 
published in The New York Times, the 
public response and the purpose he 
derived from writing surprised him. 
In the essay, he shared his feelings 
about the devastating diagnosis, his 
quest for certainty in statistics, and 
how the words of Samuel Beckett,  
“I can’t go on. I’ll go on,” helped him 
move forward. Then, a relapse this 
spring required chemotherapy and 
two hospitalizations. “Relapsing 
means again finding a way to get back 
involved in the world,” he said.
Lee was also just 36 years old 
when, in November 2010, a spon-
taneous arterial dissection led to a 
stroke that paralyzed him from head 
to toe on his left side. It also affected 
his speech and ability to multitask.
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and recovery. “Being able to grieve 
and mourn what has been lost is 
human,” he shared. “It is important 
to accept that bad things happen 
that are entirely out of your control. 
The only control you have is how 
you respond.”
Practicing medicine ensures 
regular encounters with disease, 
disability, and death. But when 
the physician becomes the patient, 
confronting illness can take on 
new meaning. Lee and Kalanithi 
both stressed the importance of 
a strong support system, finding 
purpose, and participating in life. 
Kalanithi completed his residency 
in June 2014 and is trying to regain 
stamina so that he can enjoy being 
a father, continue writing, and per-
haps perform neurosurgery again. 
Lee is re-engaging in sports and is 
researching therapeutic hypother-
mia for cardiac arrest survivors. He 
hopes to return to clinical practice. 
“Resilience is like the third act of a 
movie,” Lee said. “There’s always 
some obstacle to overcome.”
—Katherine L. Kraines
In the four years since the stroke, 
Lee, who is working on a Ph.D. in 
investigative medicine, has pro-
gressed from a wheelchair to a cane 
to walking independently, and his 
speech is now completely normal. 
Focusing on work has helped him 
rebound cognitively and emotion-
ally. He recently passed the writ-
ten and oral qualifiers for his Ph.D. 
program. “It is huge. It’s reaffirm-
ing to know that I can do this and 
it feels good. It makes me feel like 
a whole person again,” Lee said. 
“Appreciating each new accomplish-
ment gives me perspective when  
life feels difficult.”
For Lee, resilience at its core 
means perseverance in the face of 
the severity of his paralysis and the 
cognitive hit from the stroke. “I 
am constantly reminded of things 
I used to take for granted. Who 
thinks twice about walking across 
the kitchen to get a drink?” said Lee, 
an avid athlete prior to the stroke. 
“Are you going to persevere? Are you 
going to live and reclaim your life 
from adversity?”
Lee walks with a limp and has 
some gait and stability issues. He 
doesn’t have full use of his left 
hand, and it is uncertain how much 
he’ll recover. A former snowboard 
instructor, he said that his fam-
ily’s prodding sent him back to the 
slopes with adaptive equipment last 
winter. It was a great experience, 
but he admits feeling conflicted 
about trying old activities in new 
ways. “It’s really an ego thing—you 
can’t let your ego get in the way  
of doing things,” he said. “I’m 
learning to accept that life won’t  
be just like it was before. And  
I’ve realized that I need to take 
advantage of things that I’m resis-
tant to embracing.”
But Lee also feels that acknowl-

















“We are no match for these  
creatures,” says microbiologist 
Jorge Galán of such bacteria as  
Salmonella, which have proven 
their resilience over time. Mi-
crobial pathogens, he says, have 
evolved unique ways to interact 
with their hosts, and terms of  
this interaction often reflect the 
co-evolutionary balance that  
the host and pathogen must reach 
in order to survive.
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A bug’s journey
 How evolution and selection  
help microbes adapt to  
  changing circumstances












You go to the doctor. The source? Salmonella. Do you 
go home with an antibiotic? Hopefully not, said Jorge 
Galán, Ph.D., D.V.M., chair and the Lucille P. Markey 
Professor of Microbial Pathogenesis and professor of 
cell biology. The frequency of antibiotic resistance 
tends to be high, Galán said, so there is a chance that 
such a drug may not work. More importantly, an 
antibiotic will wipe out your intestinal flora—the 
gut bacteria that otherwise would compete with the 
pathogenic intruders, leaving the resistant bugs to 
thrive unimpeded. A good doctor will not prescribe 
antimicrobials in this case, Galán says, because  
that could turn a few days’ discomfort from a self-
limiting infection into a lethal outcome.
 So you think  
you have food poisoning.
A bug’s journey
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It’s for that same reason that if you do end up needing anti-
biotics, doctors urge you to finish the course even after  
you feel better in order to kill every last bug. Not doing so 
could leave you—and the world—with resistant infections.
From the human perspective, the emergence of 
antimicrobial resistance is a public health nightmare. 
For microbes, however, the ability to flourish in the 
face of a drug challenge is a success story and one of 
resilience: the ability to bounce back from challenges.
We tend to think of human resilience as the way 
in which individuals recover from such setbacks as 
the loss of a job or a loved one. Microbial resilience, in 
contrast, operates at the population level. When faced 
with an environmental change or selective pressure, 
individual microbes that are genetically unprepared 
simply die—but those that remain, such as the resis-
tant Salmonella enterica Galán speaks of, are suited 
to their circumstances and can flourish, benefiting the 
microbial population. Through natural selection, bugs 
can evolve to withstand almost anything.
“masters of evolution”
Galán likes to engage his students in a thought experi-
ment. If you wanted to perpetuate your genes forever, 
he asks, and could choose between having a brain the 
size of Connecticut or being able to reproduce every 
20 minutes, which would you pick? “To me, it’s a 
pretty easy choice,” Galán said. “The replication every 
20 minutes combined with genetic plasticity to change 
the genetic content will ‘outsmart’ the brain the size of 
Connecticut. We are no match for these creatures.”
Bacteria exhibit impressive genetic diversity, but 
such RNA viruses as hepatitis C, poliovirus, influenza, 
and HIV are diverse to a gargantuan degree. Brett D. 
Lindenbach, Ph.D., associate professor in the depart-
ment of microbial pathogenesis, calls RNA viruses 
“masters of evolution.” Their populations are so varied 
that no matter what situations they face, some will 
have the genetic makeup to survive.
At work behind this microbial resilience are the 
concepts of genetic diversity and followed by natural 
selection. We often think of mutations as mistakes and 
sources of human disease, but they are simply genetic 
changes, and sometimes they are beneficial. Mutations 
are in fact critical to microbial survival, assuring  
that in any population at least one bug will survive  
any situation. Bacteria and viruses share high genetic 
diversity, but they achieve it in different ways.
First, some background. Bacteria have DNA 
genomes, the genetic blueprints that they pass on  
to their offspring; viruses may have either RNA or  
DNA genomes. Lindenbach studies RNA viruses.  
The enzymes that make copies of the genetic material, 
either RNA or DNA, during microbial replication are 
called polymerases.
how mistakes make bugs stronger
To generate diversity, RNA viruses like those 
Lindenbach studies depend largely on replication mis-
takes. The RNA polymerase of the hepatitis C virus, 
for example, makes so many mistakes that every new 
virus particle produced contains on average one muta-
tion. “That’s an incredibly high error rate,” Lindenbach 
said. In comparison, the error rates for bacterial DNA 
polymerases are 1,000 times smaller.
Because of this high error rate, the evolution of  
RNA viruses diverges from the traditional “survival of  
the fittest” model, which predicts that for any gene, 
the version that confers the greatest selective advan-
tage will become dominant. But that’s not how it 
works for RNA viruses. Because their polymerases are 
so prone to error, rather than having a single “correct” 
sequence, RNA viruses exist in what microbiologists 
call “swarms” or “clouds,” hovering around theoretical 
master sequences but constantly deviating from them, 
the way individual bees in a swarm shift in space rela-
tive to the general path of their group.
“RNA viruses really are masters of evolution,” 
Lindenbach said, “because [in] fairly short generation 
times they give rise to large populations of divergent 
daughter genomes, and then evolution can just take over.”
Not only do RNA viruses tolerate their faulty poly-
merases; they actually depend on their “mistakes.” 
Lindenbach noted that the Kirkegaard laboratory at 
Stanford compared the survival of different polio-
virus clones whose polymerases had different error 
rates. The researchers found that mistakes were valu-
able to the viruses. “The idea is that the virus needs a 
certain amount of variability in order to adapt to the 
environments that it’s encountering in an animal,” 
Lindenbach explained.
Beyond mutation, bacteria have additional ways to 
achieve genetic diversity that viruses lack. Different 
strains of bacteria can exchange genetic material with 
each other in what’s called horizontal gene trans-
fer—horizontal because it occurs within a generation 
rather than during reproduction. There are three ways 
in which horizontal gene transfer can happen: trans-
formation, in which a bacterium takes up a closed 
loop of DNA called a plasmid from the environment; 
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As humans, we think of resilience 
as the ways in which individuals 
recover from setbacks. Microbial 
resilience, however, operates at 
the population level. When faced 
with environmental changes or 
selective pressure, microbes that 
are genetically unprepared simply 
die—but those that remain can 
flourish. Through natural selec-
tion, microbes like Salmonella (in 
yellow) can evolve to withstand 
almost anything.
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transduction, in which a bacteria-infecting virus, 
a bacteriophage, moves DNA from one bacterium to 
another; and conjugation, in which two bacteria con-
nect physically and DNA passes from one to the other. 
Bacteria use all three methods to achieve genetic 
diversity, Galán said, making mutation relatively less 
important to bacteria in comparison to RNA viruses.
Then there is the issue of replicating every 20 minutes 
—or rapidly, anyway. The more frequently microbes rep-
licate, the more opportunities they have to experiment 
with genetic possibilities and the faster they can adapt. 
It’s hard to compare the replication rates of viruses and 
bacteria, Lindenbach said; they replicate very quickly 
within a cell, but outside their hosts they can spend 
periods of time not replicating at all. In the scheme of 
things, viruses also have short life cycles.
Though genetic diversity is useful overall, individual 
mutations are usually harmful. For example, a study 
of one RNA virus, vesicular stomatitis virus, found 
that 60 percent of mutations were deleterious. There 
is, therefore, a limit to the frequency of mistakes that 
RNA viruses can tolerate. If viruses accumulate so 
many mistakes that they destroy their essential genes, 
Lindenbach said, they will go extinct in what’s termed 
an error catastrophe.
f inding unknown strengths
It’s a common theme in movies. Our heroes live quiet  
and unremarkable lives until disaster strikes. Suddenly,  
the characters find strength that they didn’t know they 
had. In an analogous way, the importance of genetic 
diversity becomes clear when environmental condi-
tions change and the pressure of natural selection is 
applied. The most familiar kind of selection, and the 
one that gets public health attention, is that of an anti-
microbial drug.
Resistant strains of tuberculosis, a disease that is 
topped only by HIV in the number of people it kills 
annually worldwide, emerged as soon as doctors began 
treating TB with antibiotics in the 1940s. Since then, 
drug resistance has spread in frequency and geographic 
scope—450,000 cases of multidrug-resistant TB were 
reported around the world in 2012. Drug-resistant 
strains of malaria, gonorrhea, and Staphylococcus 
aureus (better known as MRSA) also threaten 
global public health. Take it from the World Health 
Organization (WHO): Antibiotic resistance is  
“a problem so serious that it threatens the achieve-
ments of modern medicine,” states a 2014 report on 
antimicrobial resistance. “A postantibiotic era—in 
which common infections and minor injuries can kill—
far from being an apocalyptic fantasy, is instead a very 
real possibility for the 21st century.”
Of course, not only bacteria but also RNA viruses 
like hepatitis C become resistant to drugs. For example, 
nucleoside analogs are one class of drugs that have 
been developed against hepatitis C; they work by inter-
fering with the viral RNA polymerase. Mutations in the 
polymerase that prevent the drugs from binding can 
confer resistance to the drugs, Lindenbach said.
There is a silver lining, however, because in this 
case, the mutations that confer drug resistance come 
at a cost to viral fitness. “Those mutations also attenu-
ate the normal function of the polymerase, even in the 
absence of the compound,” Lindenbach said, “so that 
those viruses that have that mutation are resistant to 
the polymerase, but they’re very weak viruses.”
hope for future antimicrobials
Galán believes that, in the future, antimicrobial drugs 
will be designed not to test microbial resilience. “In 
terms of dealing with pathogens,” he said, “a strategy 
that is beginning to gain some traction, and that some 
of us have been preaching for a long time, is instead 
of developing drugs to kill the bug, the notion is to 
develop drugs that will hamper its ability to cause dis-
ease and then let our defense mechanisms deal with 
it.” By chance, some bugs may well resist the drugs, 
but others will be susceptible. The key is that with 
this new kind of drug, the resistant microbes will not 
be the only ones left alive, and they will therefore not 
come to dominate the way they would under the selec-
tive pressure of a microbe-lethal agent. 
Designing drugs that tweak microbial machinery to 
prevent disease will require a specific understanding  
of the way in which that machinery works. This is 
exactly what Lindenbach and Galán spend their days 
doing. “As we know more and more how pathogens 
engage the host, cause disease, enter cells, attach to 
cells,” Galán said, “then we can develop highly specific 
drugs that will target those abilities.” /yale medicine





















 The fight to 
control smoking
A photograph of Harvey W. 
Cushing, M.D., lies flat in one 
of the glass cases that ring 
the rotunda in the Cushing/
Whitney Medical Library.  
In the picture, the pioneer-
ing neurosurgeon leans 
against a stone barrier along 
the Axenstrasse roadway in 
Switzerland, his face pen-
sive as he peers at unseen 
landscapes, a cigarette bal-
anced easily in his left hand. 
Next to the photo sits an 
advertisement: “More doc-
tors smoke Camels than any 
other cigarette.”
  How anti-smoking efforts pushed  
 back against the tobacco industry
  By Kate Wheeling
matchbooks; and tobacco 
ads regularly appeared 
on primetime television. 
Americans spent much of 
the 20th century cloaked in 
clouds of cigarette smoke.
By 1964, the year of the 
first U.S. Surgeon General’s 
Report on Smoking and 
Health, 70 million Americans 
were smokers. Nearly half 
of all adults smoked, fuel-
ing an $8 billion industry. 
Smoking’s negative health 
effects were well known, 
but tobacco sales remained 
unregulated even as the 
famed Marlboro men began 
to die of smoking-related dis-
eases like chronic obstructive 
pulmonary disease.
The photo and ad are part 
of a library exhibit highlight-
ing the dueling campaigns 
of the tobacco industry and 
the anti-smoking movement. 
“Selling Smoke: Tobacco 
Advertising and Anti-smoking 
Campaigns” ran from May 15 
through Sept. 12.
The tobacco industry is 
notorious for shamelessly 
persuasive advertising, using 
everything from sex to Santa 
to sell its products. They 
hired celebrity spokespeople 
(“Smoke [Philip Morris] for 
pleasure today,” says Lucille 
Ball, of I Love Lucy, in an 
ad. “No cigarette hang-
over tomorrow,” adds her 
husband and co-star Desi 
Arnaz); advertised promo-
tions and giveaways (“1,000 
gifts you can get for free with 
B&W Raleigh Coupons …”); 
and even touted supposed 
health benefits (“Smoking 
Camels has been found to 
have a marked beneficial 
effect on digestive action. … 
Camels set you right!”). The 
industry aimed to integrate 
smoking into everyday 
life and largely succeeded. 
Appliance companies gave 
away lighters with refrig-
erators; restaurants and 
businesses advertised on 
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FROM FAR LEFT TO RIGHT 
A 1959 ad exhorted readers 
to “Play it smart” and “Get 
the honest taste of a LUCKY 
STRIKE.”
“For real taste, Camel beats 
them all.” This ad featured 
a 1960 graduate of the 
Yale Law School, Graeme 
Howard Jr.
Lucille Ball and Desi Arnaz, 
stars of the wildly popular 
1950s TV show I Love Lucy, 
extolled the pleasures of 
Philip Morris cigarettes.
By the 1970s, the American 
Cancer Society was push-
ing back against cigarette 
advertising, as with this 
1977 ad that warned of 
the dangers of smoking to 
unborn children.
The American Lung Asso-
ciation, in an ad from 1982, 
told smokers that their chil-
dren and pets were at risk 
from second-hand smoke.
BELOW 
Place cards from Lucky 
Strike did double duty as 
bridge favors, with a place 
to tally scores on the back. 
Users could insert ciga-
rettes in the holes to act as 
legs for the Swiss man and 
Scottish woman. A match in 
the man’s hand could serve 
as a stick or a sword.
“The funny thing is the 
Food and Drug Administra-
tion didn’t step in to try to 
extensively regulate tobacco 
until 1996,” said Melissa 
Grafe, Ph.D., the John R. 
Bumstead Librarian for 
Medical History and a cura-
tor of the exhibit. “But the 
Federal Communications 
Commission and the Federal 
Trade Commission engaged 
early in the fight against the 
tobacco industry, especially 
concerning false advertising.” 
The FTC brought lawsuits 
against cigarette companies 
as early as the 1930s for  
misleading advertisements. 
The American Cancer Society 
and the American Lung 
Association took up  
the fight against Big Tobacco, 
but what really launched  
the anti-smoking movement 
was secondhand smoke.
All told, cigarettes caused 
100 million deaths in the 20th 
century, and many of the 
dead were nonsmokers. “I 
remember getting on a plane 
and asking for a nonsmoking 
seat,” recalled Jocelyn Malkin, 
M.D. ’52, who identified 
smoking as a risk factor for 
cancer in her medical school 
thesis. “I was in a nonsmok-
ing seat, but the seat next to 
me was a smoking seat. That’s 
what was going on and it 
wasn’t so long ago.” Smoking 
wasn’t banned on domestic 
flights in the United States 
until 1998.
Lawsuits against the 
tobacco industry by innocent 
victims of tobacco—such as 
flight attendants stuck for 
hours in airliner cabins with 
smoking passengers—were 
critical to the success of the 
anti-smoking movement. 
(Other innocent victims 
included children and unborn 
babies.) “The estimate is  
that 8 million lives have been 
saved because of anti- 
smoking efforts,” said Grafe.
Today only 18 percent 
of adults are smokers, and 
26 states and the District 
of Columbia have banned 
smoking indoors. Alas, 
history may already be 
repeating itself. The use of 
traditional cigarettes may be 
declining, but e-cigarettes—
battery-operated devices 
that deliver nicotine, flavor, 
and other chemicals—are 
growing in popularity. And 
e-cigarettes are not yet regu-






























Oransky developed an interest in 
the orchestrated dissemination 
of medical and scientific news 
while a reporter and executive 
editor of the Harvard Crimson. 
Embargoes, he came to believe, 
restrict critique and force science 
journalists into a herd mentality 
of following journal publication 
schedules. He’s also concerned 
about the Ingelfinger Rule, which 
not only bars scientists from  
publishing the same original 
findings in more than one outlet  
but also scares some of them out 
of talking to the press. Though 
the rule is well intentioned, 
Oransky feels it constricts the free 
flow of scientific information.
 Straddling medicine and journalism, a  
former resident keeps an eye on the science press
»
I VA N OR A N S K Y, M.D.,  H S ’99,  I S N’ T S H Y A B OU T RU F F L I NG F E AT H E R S, and 
he wants the medical community to share his concerns about the ways in which 
medical and scientific news reaches scientists and the public. Oransky is the co-
creator of the science publishing watchdog site Retraction Watch, and in 2013 he 
became the global editorial director for MedPage Today, an online news service 
for physicians. After 15 years as a full-time medical journalist, Oransky uses his 
role at MedPage Today to communicate his passion about the importance of skep-
ticism in both reporting and medicine. 
“Thinking about how journals 
and the media control the flow 
of information is important to 
everyone, including taxpayers, 
patients being treated, and  
the people doing the research 
and treatment,” he mused. 
“Any practicing doctors should 
understand how the sausage is 
made, why they read only cer-
tain studies in certain journals 
or in the news, and how their 
release is timed.”
Oransky's move from medi-
cine to journalism came a year 
after he graduated from medical 
school at New York University 
in 1998. He came to Yale for a 
psychiatry internship, drawn by 
a tradition that bridged psycho-
analytic practice and modern 
psychopharmacology. Splitting 
his internship between Yale-
New Haven Hospital and the VA 
Connecticut Healthcare System 
in West Haven, Oransky also 
found time to write. He con-
tributed op-eds to USA Today 
and had a regular column in the 
Jewish newspaper The Forward 
(as “The Doctor”) where, for 
example, he wrote about the use 
of foreskin tissue in research. But 
it was his monthly column about 
life as an intern in American 
Medical News (which ceased 
publication last year) that really 
got people’s attention—and not in 
an entirely good way.
“Residents and interns worked 
a lot of hours, and I wrote hon-
estly about what it was like to be 
an intern,” said Oransky. “One 
yalemedicine.yale.edu42
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Ivan Oransky switched 
from psychiatry to a 
career as a gadfly, shar-
ing his concerns about 
transparency in the 
dissemination of medical 
and scientific news. “Any 
practicing doctor should 
understand how the sau-
sage is made,” he says.
   Ivan Oransky // 
 “Knowledge is gained by challenging what 




















of the deans wasn’t crazy about 
that.” Oransky was chastised in 
a letter that circulated to senior 
medical school faculty. Oransky 
has no regrets. “It reminded  
me that my core identity is as a 
journalist, constantly challenging 
things,” he said.
After his internship, Oransky 
chose journalism over the prac-
tice of medicine. “It wasn’t the 
easiest for my parents to get used 
to, but once they saw that I was 
really happy and accomplishing 
things and adding value to the 
world, they got it,” he recalled.  
He was hired as founding editor 
in chief of Praxis Post, a webzine 
that was dubbed “Vanity Fair for 
doctors.” Following  
that, he was deputy editor of  
The Scientist and managing edi-
tor of Scientific American. 
In 2010 Oransky started two 
blogs to keep tabs on the sci-
ence communication ecosystem: 
Retraction Watch, which ana-
lyzes research corrections and 
retractions and which he runs 
with Anesthesiology News edi-
tor Adam Marcus; and Embargo 
Watch, a site that monitors 
premature news breaks and 
the effects embargoes have on 
news coverage. After four years 
as executive editor of Reuters 
Health, Oransky joined MedPage 
Today in July 2013.
Another goal of Oransky’s is 
to create a health care provider 
blog network at MedPage Today. 
“This is clearly the next step in 
the great and rapid evolution 
of the site,” he said. “We want 
to give doctors, nurses, and 
physician assistants a voice and 
a platform to have conversations 
and share expertise and insights.” 
Oransky will be tapping estab-
lished bloggers, but said he is 
happy to hear from alumni of the 
School of Medicine in the health 
care community who would be 
interested in having their blogs 
join the MedPage network.
Blogs are powerful and lower 
the publishing barrier, said 
Oransky, and they are a great 
way for patients and doctors to 
talk to one another. While the 
line between traditional journal-
ism and blogging is blurring, a 
common thread that he carries 
through his day job and his blog-
ging is skepticism. “Knowledge 
is gained by challenging what we 
think is true and looking at the 
evidence,” said Oransky. Medical 
education, like journalism, he 
said, could always use more 




A Renaissance man  
looks back on  
50 years in medicine
Some people might call Alfonso  
Esguerra, M.D. ’64, HS ’66, FW ’69, 
a modern-day Renaissance 
man. Aside from co-founding 
a renowned medical center 
in Bogotá, Colombia, he has 
participated in civic service, 
commissioned architectural 
projects, formed philanthropic 
and social enrichment orga-
nizations, written two books 
on Latin American paternal-
ism, and established a flower 
farm that exports over a mil-
lion stems each year. Esguerra 
says these endeavors are borne 
from a “why not?” attitude and 
what he calls “responsible self-
learning”—a value ingrained in 
him by the Yale system.
Although he has enjoyed a suc-
cessful career, Esguerra did not 
always think that medicine was 
his destiny. An early fascination 
with the visual arts often com-
peted with the lure of his family’s 
tradition—both grandfathers, 
his father, and two of his three 
uncles were physicians. But it 
took only a few premed classes at 
the Universidad de Los Andes in 
Bogotá to ignite his passion for the 
biological sciences.
After completing his medical 
education at Yale, followed by 
an internship at the Hospital of 
the University of Pennsylvania, 
a radiology residency at Yale-
New Haven Hospital, and sub-
specialized training as the Yale 
William Wirt Winchester Fellow 
in Thoracic Radiology, Esguerra 
returned to Colombia in 1969 at 
age 30. He practiced radiology in 
Bogotá, where he was soon rec-
ognized for his professionalism 
and leadership. 
But Esguerra had a broader 
vision—to establish a com-
prehensive nonprofit medical 
center in Bogotá. Of course, he 
said, this venture would never 
have become a reality were it 
not for the unwavering sup-
port of his wife, Gloria, who 
also donated the land where the 
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she never knew
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As Esguerra readies to retire 
after 50 years in medicine, he 
says he “remains committed to 
becoming a better person. What 
has mattered most is making a 
difference as one shares and con-
tributes to community interests.” 
Esguerra looks forward to spend-
ing quality time with Gloria; 
their two daughters, Beatriz and 
Maria, their sons-in-law, and 
their four grandchildren. He also 
plans to document the history of 
FSFB, paint, tend to his garden, 
cook. “… and someday soon, visit 
New Haven to enjoy once more 
the bells of the Yale carillon, as 
they play Cole Porter songs.”
—Amanda Crowe
After a successful 
career as a physician 
in his native Colombia, 
Alfonso Esguerra pursued 
a broader vision—to  
establish a comprehen-
sive medical center in 
Bogotá. Under his leader-
ship a plot of land in the 
Andean foothills has 
become a major center.
hospital stands. Their first recruit 
for the project was José Félix 
Patiño, M.D. ’52, HS ’58, a former 
Colombian minister of health. “It 
took me two years to convince 
him of the idea and instill in him 
the enthusiasm Gloria and I felt 
for the project,” Esguerra said.
The Esguerras and Patiño 
were among the six founding 
members of Fundación Santa Fe 
de Bogotá (FSFB) in November 
1972. It would take seven 
years to obtain financing from 
Colombia’s banking community. 
Another Yale alumnus, architect 
George Nelson, B.F. Arch. ’31, 
designed what Esguerra envi-
sioned to be “a hospital so 
humane it would not look like  
a hospital.” Nelson dubbed  
the project “The Colombian 
Garden of Health.”
In 1979, Esguerra was named 
the general director of FSFB, 
charged with “getting the job 
done.” It was no small task. He 
began by forming an executive 
team, and hiring hospital plan-
ners and equipment consultants. 
He supervised the hospital’s 
construction, and participated 
in selecting the members of a 
top-notch medical staff. FSFB 
opened its doors on January 31, 
1983. Two years later Esguerra 
considered “the job done” and 
resigned his post.
A 7.5-acre plot of land in a 
tree-lined neighborhood at the 
foot of the Andes Mountains 
became a major medical center 
under Esguerra’s leadership. 
Today it consists of a tertiary 
care hospital, an outpatient 
specialty clinic, an emergency 
clinic, and an oncology institute 
serving 150,000 patients a year. 
It operates within Colombia’s 
national health system, which 
insures more than 90 percent of 
the population. Esguerra is most 
proud of the degree of institu-
tionalization FSFB has achieved. 
“It should be the organizational 
characteristic of all major Latin 
American enterprises,” he adds.
After extensive self-retraining, 
Esguerra returned to radiology 
in 2002 following a 20-year  
hiatus. As chief of the chest  
section in the FSFB diagnostic  
imaging department, he found-
ed the Center for Interactive 
Digital Education in Radiology 
(CIDER) and its companion  
website (fsfbcider.org), of which 
























In the three years since, 
Alexander has undergone 
22 surgeries at Yale-New 
Haven Hospital and has 
another handful ahead of 
her. That she survived at all 
is impressive, but even more 
remarkable is her approach 
to life in the wake of the 
accident. A long-time activ-
ist for community service 
and human rights, she now 
advocates for road safety and 
raises money for organiza-
tions that have played a role 
in her recovery. Since the 
injury she has participated in 
more than 30 races, includ-
ing eight triathlons and two 
Ironman events. A buildup 
of scar tissue limits her 
mobility, and she can only 
run slowly—she had to walk 
during 90 percent of her last 
Ironman—but she is proud to 
cross the finish line at all and 
is redefining what it means 
to be an athlete.
Alexander, 39, credits  
a large part of her recovery  
to her medical team at Yale 
and the support of her hus-
band, but it is clear that her  
exceptional resiliency and 
spirit have spurred her achieve- 
ments. She spoke with Yale 
Medicine this summer about 
how she has managed to 
thrive despite unremitting 
pain and the limitations 
caused by her injuries.
  Colleen Kelly Alexander flatlined  
twice after being hit by a 30-ton truck.   
   Now, she’s running marathons.
watch a short film about 




C OL L E E N K E L LY A L E X A N DE R K NOWS W H AT I T M E A N S T O 
B OU NC E B AC K. An experienced triathlete, she was cycling home 
from work one day in October 2011 when a 30-ton truck ran 
through a stop sign and over her on Boston Post Road in Madison, 
Conn. Her injuries were overwhelming: her lower body was 
ripped apart, her pelvis was crushed, and she flatlined twice after 
nearly bleeding to death.
{To nominate a subject for Q&A, contactYale Medicine, 1 Church Street, Suite 300, New Haven, CT 06510 or email ymm@yale.edu
The trauma you suffered 
would be life crippling in a 
different person. Why do 
you think this hasn’t been 
the case with you? None 
of these injuries have made 
me lie on the couch because 
there’s no room for that in 
my life. Too many people 
worked too hard; too many 
people gave their blood, 
gave their time, gave their 
energy, gave their prayers. 
For me, giving up was never 
an option.
How important was your 
previous athletic training to 
your physical and psycho-
logical recovery? Being an 
athlete prior to being run 
over has been a blessing and 
a curse. For a very long time 
I wasn’t able to leave the 
bed. The athlete in me was 
always screaming to get back 
out there to run and to bike 
and do all these things that 
I love. Suddenly, all of that 
was taken away. My dad said 
to me that when athletes are 
injured it’s a bigger curse 
than if you’re not an athlete, 
because all you know is that 
active lifestyle, and sud-
denly it’s taken away from 
you and it’s such a huge loss. 
But what it did provide me 
with was a strong, beating 
heart. So being an athlete 
has allowed me to sit here 
today and be shining, which 
is really nice.
Since the accident, you’ve 
dedicated yourself to physi-
cal activity and social activ-
ism. What made you choose 
this route? I was an athlete 
and activist before, so I’m not 
going to let the poor choice 
of someone that blew a stop 
sign ruin my life. Certainly, 
I’ll never be the athlete that 
I could have been, or the 
mother, or the wife, but I am 
who I am now, and I’m so 
grateful for this life and I’m 
grateful for this opportunity. 
If anything, it fuels me even 
more because I want to be able 
to get out there and move and 
be active and show people that 
anything is possible.
trauma. After the almost 
seven weeks at Yale-New 
Haven Hospital and close 
to three months at Gaylord 
Hospital, I finally developed 
depression and anger and 
frustration, and I remem-
bered those words. And I 
thought, if I’m this angry 
and in this much pain, I can 
harness this and do some-
thing with it. That began a 
change in my outlook.
You’ve said that during 
triathlons you need to pull 
over and cry at least once. 
Why and what makes you 
keep going? I’ve got this 
hidden battle inside. As my 
heartbeat picks up and my 
breathing picks up, it brings 
me back to the accident. So 
that fear that I have starts to 
take over—and it does take 
over—when I pull over to the 
side of the road, that’s when 
I offer up gratitude that I’m 
on this earth.
How chronic is your pain? 
How do you compete and 
function while in pain? I am 
in pain, but I’m not going to 
let it completely define me. 
I’ve had pain way past a 10.  
I typically hover around a six. 
Sometimes I spike up, some-
times I go down to a two or 
three. I made a decision early 
on that I wasn’t going to 
take heavy drugs more than 
I needed to because I knew 
there was a chance of addic-
tion, and I didn’t want that 
to be an option. If I wasn’t  
in weekly psychotherapy,  
I would have a much tougher 
time handling my pain.
You’ve had the opportunity 
to meet some famous and 
wise people, such as Jody 
Williams, who won the 
Nobel Peace Prize in 1997 
for her efforts to ban land 
mines. Did they shape your 
philosophy? Jody Williams 
was my kick in the pants. 
I met her years ago prior 
to the trauma. Her words, 
“emotion without action is 
irrelevant,” were very much 
a mantra for me prior to this 





We covered Colleen's 
start on the road to  
recovery about a year 
after the accident. 
Visit yalemedicine.yale.
















 How cats and dogs 
became our best friends
By the time they graduated 
from the School of Medicine, 
David Grimm, Ph.D. ’04, and 
his fiancée, Amy S. Duffield, 
M.D. ’05, Ph.D. ’05, had 
wanted a cat for years. After 
landing in Baltimore—Grimm 
as a deputy news editor 
of Science, Duffield as a 
pathology resident at Johns 
Hopkins—they felt ready to 
adopt two kittens. Not long 
after, one of the kittens spent 
three days in a veterinary ICU. 
The bill came to nearly $3,000.
Why, Grimm wondered, 
had he and his fiancée gone 
into debt to save the kitten? 
He decided to explore what 
he describes as “the evolution 
of dogs and cats from wild 
animals to quasi-citizens.” 
Americans, he soon discovered, 
spend a lot on their cats and 
dogs—$55 billion in 2013—and 
more households have dogs or 
cats than have children.
His research took him 
to laboratories, animal 
shelters, an animal law con-
ference, and a prison. The 
result is Citizen Canine: 
Our Evolving Relationship 
with Cats and Dogs, a broad 
examination of the history 
of how humans interact 
with dogs and cats and how 
the pets have affected art, 
religion, law enforcement, 
public policy, and even the 
course of epidemics.
Grimm, who studied 
genetics at Yale, begins 
by investigating how dogs 
evolved. The household pet 
we know as Canis lupus 
familiaris shares 99.9 percent 
of its DNA with the gray wolf, 
Canis lupus. One explana-
tion for the evolution is “pup 
abduction”—our ancestors 
may have kidnapped wolf 
pups and raised them to be 
gentler than wild wolves. 
But Grimm doubts that the 
abductors would have imag-
ined that wolves could be 
made gentle: people found 
them terrifying. (Consider 
Little Red Riding Hood, a tale 
told by two other Grimms.) 
Furthermore, early humans 
had yet to domesticate any 
animal. As one scientist tells 
Grimm, “They weren’t think-
ing, ‘You know, in a century 
or two, we’ll create this really 
handy animal, the dog.’ ”
A more likely scenario, 
Grimm believes, is that 
wolves evolved somewhere 
between 15,000 and 30,000 
years ago as they followed 
early humans, scavenging 
for bones and food scraps. 
Humans in turn found 
canines useful for carrying 
loads and warning of intrud-
ers. Cats proved similarly 
valuable with the advent of 
agriculture about 12,000 
years ago—they killed mice 
that ate stored grain.
A 20th-century experi-
ment showed how quickly 
human-animal interactions 
can lead to genetic changes: 
the Russian geneticist Dmitri 
Belyaev began in 1959 to 
breed caged silver foxes 
selectively, allowing only the 
friendliest to reproduce. In 
just nine years, the foxes’ ears 
became floppy, their tails 
curled, and they had lower 
levels of the stress hormone 
cortisol. Instead of biting 
people, they licked their 
hands. Grimm also notes 
reversals in the fortunes 
of dogs and cats—whereas 
ancient Egyptians venerated 
felines, in 1233 Pope Gregory 
linked cats to Satan. Millions 
of cats were massacred, a 
boon to the rats that helped 
spread the plague.
The social standing of 
cats and dogs has improved 
markedly since then. Support 
for medical experimenta-
tion on animals is waning. 
Laws protect animals from 
harsh treatment, and among 
Grimm’s field trips was a stint 
shadowing the anti-cruelty 
team of the Los Angeles 
Police Department as they 
investigated the beheading 
of two dogs. Americans view 
their dogs and cats as family 
members: during Hurricane 
Katrina in 2005, people 
risked death rather than leave 
their pets behind.
Grimm’s account brings 
us to an era in which canines 
and felines increasingly 
look almost like citizens. As 
Grimm demonstrates, the 
story of our bond with cats 
and dogs is still unfolding.
 A Yale-trained geneticist looks at how humans   
   turned wild animals into beloved pets
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book review
K Y L A HOR N (in photo), a neuroscience student, makes 
a point of visiting Finn the Therapy Dog in the medical 
library on Fridays.
“He helps me take a breather from everyday stress and 
just live in the moment for a while,” says Horn.
Horn is not alone in appreciating a few minutes with 
the gentle 3-year-old mix. Horn’s visit in early September 
came a few days before Finn appeared on The Today Show 
on Sept. 9 in a segment about the Canine Cognition Center 
at Yale. The segment showed Finn and two other dogs tak-
ing tests to determine whether they trust their owners and 
can distinguish between “good” and “bad” puppets.
Finn’s owner, Krista Knudson, M.S.N., a nurse prac-
titioner in a doctoral program at the School of Nursing, 
enrolled Finn in the center’s research project a few months 
ago. “His temperament lent itself to being the one that got 
showcased,” Knudson said.
—John Curtis
 Laid-back  
‘spokesdog’ on TV
end note
